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NANOSCALE ORGANIZATION OF THE SMALL GTPASE RAC1
Abstract
Kelsey Maxwell, B.S.
Advisory Professor: John F. Hancock, M.A., M.B., B.Chir., Ph.D.

Rac1 is a small, guanine-nucleotide binding protein that cycles between an
inactive GDP-bound and active GTP-bound state to regulate actin-mediated motility,
migration, and adhesion. Plasma membrane (PM) localization is essential for its
biological activity. Rac1 PM targeting is directed by a C-terminal membrane anchor that
encompasses a geranylgeranyl-cysteine-methyl-ester, palmitoyl, and a polybasic
domain (PBD) of contiguous lysine and arginine residues. Using high-resolution imaging
combined with spatial mapping analysis, I found that Rac1 forms nanoclusters on the
PM. Cycling between the GTP- and GDP-bound states, Rac1 forms nanoclusters that
are non-overlapping, consequently undergoing guanine nucleotide-dependent spatial
segregation. I further found that Rac1 selectively associates with phosphatidic acid (PA)
and phosphoinositol (3,4,5)-trisphosphate (PIP3), resulting in nanoclusters enriched in
these anionic lipids. I found these lipids to be structurally important as depleting the PM
of PA or PIP3 impaired both Rac1 PM targeting and nanoclustering. Lipid binding
specificity of Rac1 is encoded in the C-terminal PBD amino acid sequence in combination
with the adjacent lipid anchors. Point mutations within the PBD, including highly
conserved arginine to lysine substitutions or mutations exchanging the geranylgeranyl
for farnesyl, profoundly altered Rac1 lipid binding specificity without changing
electrostatics of the protein and resulted in impaired macropinocytosis and decreased
cell spreading. In this thesis, I proposed that Rac1 nanoclusters act as lipid-based
signaling platforms emulating the spatiotemporal organization of Ras proteins and further
vi

showed that the Rac1 PBD-prenyl anchor has a biological function that extends beyond
simple electrostatic engagement with the PM.
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Chapter 1
Introduction
Ras-related C3 botulinum toxin substrate 1 (Rac1) is a ubiquitously expressed
small GTPase that regulates a number of diverse cell signaling processes. Rac1
signaling is spatially organized and initiated on the plasma membrane (PM), where it
interacts with effector proteins and signaling lipids. As a consequence of its localization,
Rac1 function is dependent on the complex behavior of the plasma membrane. Cell
membranes are multifaceted and heterogeneous, containing a wide variety of domains
and compartments that differ in their biophysical components and properties. The PM
must also respond to the extracellular environment and selectively take in nutrients, while
at the same time screen non-beneficial substances. In order to regulate signaling, recruit
binding partners, and maximize signaling efficiency, many lipids and PM-localized
molecules form complexes or clusters on the cell PM.
The ability of lipid-anchored and transmembrane proteins to form clusters has
been a growing area of research. For example, Ras small GTPases form lipid-enriched
oligomers that are essential for downstream signaling and in effect, act as signaling
platforms for effector binding and recruitment on the PM. In this study, I discover the
existence of nanometer scale clusters of active Rac1, distinct from Ras isoform-specific
nanoclusters or inactive Rac1, which suggests a novel means of regulation for Rac1
signaling. Elucidation of these Rac1 clusters would shed light on the functional
significance of Rac1 spatial organization and PM targeting. Therefore, the objective of
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this dissertation is to identify the structural components and functional relevance of Rac1
nanocluster formation.

1.1 Membrane domains and plasma membrane complexity
The fluid mosaic model of cell membranes was first proposed almost fifty years
ago in a ground-breaking article by S.J. Singer and G.L. Nicolson. In this model, the
plasma membrane consists of a lipid bilayer with embedded proteins, giving rise to
membrane fluidity and malleability, while also restricting lateral diffusion of membrane
components (Singer & Nicolson, 1972). A major assumption of this model is that the fluid
bilayer contains distinct domains defined by regions with divergent protein and lipid
compositions. Thereafter, experimental evidence began to identify the existence of
distinct membrane domains on micrometer scales, including those that may recruit
glycolipid-anchored proteins (Ahmed et al., 1997, Brown & Rose, 1992, Varma & Mayor,
1998, Yu et al., 1973). For example, early experiments using non-ionic detergents
establish that cell membranes can be divided into detergent-soluble membranes (DSMs)
or detergent-resistant membranes (DRMs) with distinct compositions (Hanada et al.,
1995, Schroeder et al., 1994). The problem with this approach however is that the
composition of DRMs and DSMs can vary widely depending on the types of detergents
and experimental conditions used and do not necessarily reflect the native composition
of membrane domains (Schuck et al., 2003). Increasing the complexity, membrane
compositions are incredibly diverse between cell types and are not necessarily
homogenous even within cell types (Levental & Veatch, 2016, Sezgin et al., 2017, van
Meer et al., 2008).
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The discovery and use of biophysical tools such as computational modeling, giant
unilamellar vesicles (GUVs), and giant plasma membrane vesicles (GPMVs) strongly
demonstrate that lipids adopt distinct phases that are solid-like or fluid-like, characterized
by their spatial arrangement and molecular freedom within the different phases (Levental
& Veatch, 2016, Sezgin et al., 2017, van Meer et al., 2008) (Fig. 1). The solid-like phases
came to be known as lipid rafts and are enriched with sphingolipids and cholesterol. The
lipid raft model theorizes that freely diffusing yet stable lipid rafts act as functional
regulatory

platforms,

selectively

coordinating

protein-protein

and

protein-lipid

interactions on the PM (Hancock, 2006, Levental et al., 2010). These rafts are between
10-200 nm in diameter but can be prompted to form larger domains (> 300 nm) by
interactions with proteins and lipids (Pike, 2006, Sezgin et al., 2017). Due to their size
and transient nature, direct observation of these rafts in vivo via classical microscopy
methods has remained elusive. However, single-particle tracking (SPT) (Kusumi et al.,
2005, Suzuki, 2016), fluorescence resonance energy transfer (FRET) (Rao & Mayor,
2005), and the electron microscopy (EM) techniques used herein (Chapter 2, Materials
and Methods), combined with advanced in vitro (Kahya et al., 2004) and in silico
(Ingolfsson et al., 2014, Niemela et al., 2007) modeling, support the existence of such
domains and provide important clues as to their nature and functional relevance (Sharma
et al., 2004, Simons & Ikonen, 1997).
The PM contains a plethora of different lipids, and lipid type greatly determines
membrane domain assembly and function. Indeed, the disparity in head groups and
aliphatic chains of lipids leads to the generation of thousands of different lipid species in
a given eukaryotic cell (Sud et al., 2007). However, the synthesis and distribution of
different lipid species is not homogenous, and geographical production of specific lipids
contributes to the distinctive membrane compositions of organelles (van Meer et al.,
3

2008). The most predominant classes of eukaryotic membrane lipids are the
glycerophospholipids and sphingolipids (van Meer et al., 2008). Glycerophospholipids
are the most abundant structural lipids of eukaryotic membranes and include
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PtdSer),
phosphatidic acid (PA) and phosphatidylinositols (PI) (Hishikawa et al., 2014, van Meer
et al., 2008). Spatially changing the composition and packing density of these lipids
promotes curvature stress on the PM and provides the structural basis for important cell
signaling events such as membrane budding and fusion (Marsh, 2007). Sphingolipids
contain a ceramide hydrophobic backbone and hydrophobic tails and therefore exhibit a
tighter packing density than glycerophospholipids (Gault et al., 2010, van Meer et al.,
2008). These tightly packed phases of sphingolipids are integrated with cholesterol,
creating the liquid-ordered (Lo) domains associated with lipid rafts (Hancock, 2006,
Levental & Veatch, 2016).
Phosphorylated PIs can act as second messengers. While the percentage of PIs
on the PM is small (<1%), they are important for the recruitment of proteins to regions of
localized signaling on the PM and endomembranes, as well as protein kinase activation
(Falkenburger et al., 2010). For example, phosphoinositol (4,5)-bisphosphate (PIP2)
regulates transient receptor potential (TRP) channel activation (Thakur et al., 2016),
potassium channels (Falkenburger et al., 2010, Rodriguez-Menchaca et al., 2012), and
protein kinase C (PKC) signaling and intracellular calcium release through its cleavage
products diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), respectively
(Falkenburger et al., 2010). Another example, phosphoinositol (3,4,5)-trisphosphate
(PIP3), is synthesized from PIP2 by PI-3 kinase (PI3K) phosphorylation and recruits
kinases such as Akt and Src to the PM, initiating growth factor signaling (Cantley, 2002,
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Vanhaesebroeck et al., 2012); indeed, both Akt and Src are heavily implicated in cancer
formation and tumorigenesis (Altomare & Testa, 2005, Yeatman, 2004).
Furthermore, asymmetric distribution of PM lipids between the inner and outer
leaflets of the PM is functionally relevant. PtdSer and PE are normally enriched on the
inner leaflet of the PM, but when exposed to the outer leaflet by the inactivation of
flippases and activation of scramblases, PtdSer acts as an apoptotic and phagocytotic
signal (Birge et al., 2016, Segawa & Nagata, 2015). PtdSer enrichment on the inner
leaflet is also necessary for the transbilayer coupling that directs cholesterol-dependent
GPI-anchored nanocluster formation (Raghupathy et al., 2015). Lipid asymmetry across
the PM bilayer also contributes to the membrane flexibility that promotes budding and
vesicle formation (Pomorski & Menon, 2006).
Our current understanding of lipid-associated membrane domains can be logically
divided into the following four categories: (1) exclusively-lipid clusters composed of
saturated lipids, such as glycolipid clusters or ceramide domains (Harder & Simons,
1999, Zhang et al., 2009); (2) lipid-mediated protein clusters also composed of saturated
lipids, which includes Ras nanoclusters and glycophosphatidylinositol (GPI)-anchored
protein domains (Abankwa et al., 2007, Varma & Mayor, 1998); (3) separation of lipids
into liquid-liquid phases (Hyman et al., 2014), whereby Lo domains composed of
saturated lipids and an abundance of cholesterol are separate from liquid-disordered (Ld)
domains composed of primarily unsaturated lipids (Kaiser et al., 2009, van Meer et al.,
2008, Veatch & Keller, 2003); (4) induced protein-mediated lipid clusters, such as cholera
toxin binding to monosialotetrahexosylganglioside (GM1) or antibody binding to cell
surface receptors (Shi et al., 2007). I found that Rac1, like other small GTPases, is
organized into lipid-mediated protein clusters, discussed in detail in this thesis.

5

Liquid-ordered domain (Lo)

Liquid-disordered domain (Ld)

Cholesterol
Unsaturated lipid
Saturated lipid

Figure 1. Illustration of plasma membrane phase separation
In model membranes and GPMVs, PM lipids segregate based on packing density, tail
saturation, fluidity, and lipid orientation into “ordered” and “disordered” domains. These
domains are facilitated by protein-protein and protein-lipid interactions, but in turn can
modulate these interactions as well.
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1.2 Signaling complexes
Depending on random macromolecular interactions to occur in the cellular
environment is an inefficient way for signaling molecules to direct signal output. PM
targeting is one way signaling molecules are able to locally interact with one another
(Cebecauer et al., 2010). Providing even more efficiency, and the focus of this
dissertation, is the formation of transient clusters (defined as three or more interacting
elements) that facilitate protein-protein and protein-lipid interactions. The reversibility of
such complexes allows for direct regulation in turning on and off the signal as needed.
Interactions between anchored complexes on the PM and unanchored second
messengers are hypothesized to be more effective than interactions between
unanchored complexes or signaling molecules (Bray, 1998). Advances in imaging
techniques have allowed for direct visualization of micro- and nanoscale signaling
complexes, though what drives the formation of these complexes and the role they play
in regulating signaling is not completely understood.

1.2.1 Ras nanoclusters
Perhaps some of the most studied signaling complexes are Ras nanoclusters.
Ras proteins are ubiquitously-expressed, PM-anchored small GTPases that cycle
between an active, GTP-bound state and an inactive, GDP-bound state through the use
of GTPase activating proteins (GAPs) and guanine-nucleotide exchange factors (GEFs)
(Bos et al., 2007, Willumsen et al., 1984). There are three isoforms encoded by different
genes, K-Ras, H-Ras, and N-Ras, with two splice variants of K-Ras: K-Ras4B (commonly
referred to as K-Ras) and K-Ras4A (Fernandez-Medarde & Santos, 2011, Tsai et al.,
2015). Though Ras proteins demonstrate isoform-selective signaling, they all play a role
7

in tumorigenesis and are frequently mutated in human cancer (Downward, 2003, Prior et
al., 2012). Unsurprisingly, given the importance their role in cancer development, Ras
proteins control a number of cell processes, including cell growth, proliferation, survival,
and differentiation (Rajalingam et al., 2007). Finding clinically effective therapeutics
targeting Ras has proved difficult (Cox et al., 2014, Papke & Der, 2017). Therefore, the
biophysical and biochemical nature of Ras clustering on the PM is an important avenue
of research for developing novel anti-Ras compounds, and their similarity to Rac1
provides insight to Rac1 spatial regulation and biology.
Ras isoforms contain 95% sequence identity and diverge from one another
primarily in the hypervariable region (HVR) of the protein. Within the HVR is the Cterminus membrane anchoring region of the protein, which undergoes post-translational
processing to target Ras to the PM (Abankwa et al., 2007). First, protein farnesyl
transferase attaches a farnesyl chain to the C-terminal cysteine of the CAAX (C, cysteine;
A, aliphatic amino acid; X, any amino acid) motif (Reiss et al., 1990). Next, Ras moves
to the endoplasmic reticulum (ER) where the CAAX motif is cleaved by Ras-converting
enzyme 1 (Rce1), leaving only the farnesylated cysteine residue (Otto et al., 1999). The
a-carboxyl group of the farnesylated cysteine is methylated by isoprenylcysteine-Ocarboxyl methyltransferase (Icmt) (Gutierrez et al., 1989) and at this stage, K-Ras4A, HRas, and N-Ras trafficking begins to diverge with K-Ras4B. K-Ras4A, H-Ras, and N-Ras
are palmitoylated on cysteine residues in the HVR and traffic to the PM through the Golgi,
while K-Ras4B traffics to the PM through cycles of solubilization with the recycling
endosome (Apolloni et al., 2000, Choy et al., 1999, Schmick et al., 2014). Along with
polybasic domains (PBD) in K-Ras4A and K-Ras4B, each of these modifications allows
for maximal PM targeting. In fact, it is the precise but divergent mechanisms of PM

8

targeting between the different membrane anchors that determines nanoclustering of
Ras proteins and isoform-selective signaling from the nanocluster sites (Hancock, 2003,
Hancock & Parton, 2005, Prior & Hancock, 2012).
Ras nanoclusters are spatially non-overlapping, segregated by isoform-type and
GTP-binding (Abankwa et al., 2007). They are ~20 nm in diameter, contain
approximately 6-8 proteins per cluster, and are the sole sites of Raf recruitment and
extracellular signal-regulated kinase (ERK) activation on the PM (Cho & Hancock, 2013).
Raf/mitogen-activated protein kinase (MAPK)/ERK signaling is regulated by the relatively
short lifetime of Ras clusters (<1s), as nanocluster disassembly ends signal output
(Harding & Hancock, 2008). Spatial segregation of GTP-bound and GDP-bound isoformspecific Ras nanoclusters is realized in part by membrane anchor orientation interacting
with PM lipids, and conformational changes in the G-domain upon guanine-nucleotide
binding (which in turn modifies hydrophobic and electrostatic contacts between the
membrane anchor and PM) (Prakash & Gorfe, 2017).
Ras nanoclusters selectively sort phospholipids, which play a role in their
structural integrity and effector binding and recruitment (Zhou et al., 2014). For example,
K-Ras nanoclusters are dependent on PtdSer for their formation and signaling, and
depleting the availability of PtdSer with various compounds results in K-Ras
mislocalization, declustering, and decreased signal output (Cho et al., 2012, Cho et al.,
2015, van der Hoeven et al., 2013). The minimal membrane anchors of H-Ras, K-Ras,
and N-Ras attached to GFP are sufficient for PM trafficking and clustering, suggesting
that it is phospholipid contacts with the membrane anchor that determine Ras
nanocluster formation (Hancock & Parton, 2005). Indeed, phospholipid selectivity for KRas is determined by key residues in the membrane anchor (Zhou et al., 2017). Ras
clusters are also challenged by the dynamic PM environment, demonstrating sensitivity
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to membrane depolarization and bile acids that perturb membrane domains (Zhou et al.,
2013, Zhou et al., 2015).

1.2.2 Receptors
The lateral segregation of transmembrane receptors is likewise important for
signal transduction. T-cell receptors, in response to antigen presentation, stimulate actin
polymerization, cytoskeletal remodeling, and promote the organization of second
messengers at the T-cell-antigen presenting cell complex (Cebecauer et al., 2010). Rac1
plays a role in this process, activating the actin-related protein (Arp) 2/3 complex, which
promotes actin filament formation, through the WASP (Wiskott-Aldrich syndrome protein)
family verprolin-homologous protein (WAVE) complex (Huse, 2009). Activated T-cell
complexes are able to accrue hundreds of signaling molecules at the immunological
synapse and regulate the strength of the signal (Bethani et al., 2010). More recently,
these receptors were shown to localize in cholesterol-rich nanodomains, which further
aggregate into larger, more optically visible domains after antibody patching (Dinic et al.,
2015).
Likewise, some G-protein coupled receptors (GPCRs) laterally segregate on the
PM (Bethani et al., 2010). In one experiment, upon agonist or antagonist binding, a
human delta opioid receptor incorporates into sphingomyelin-rich, ‘raft’-like domains in
model membranes (Alves et al., 2005). In another example, b2-adrenergic receptors form
clusters in the nanometer range in cardiomyocytes. These nanoclusters are sensitive to
actin filament disruption, but not cholesterol manipulation, indicating that perhaps the b2adrenergic receptor is not a raft-associated GPCR (Scarselli et al., 2012). At least for
GPCRs, clustering appears to be cell-type and receptor-type dependent.
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The epidermal growth factor (EGF) receptor (EGFR) forms lipid-dependent
nanoclusters. In serum-starved conditions, EGFR prefers cholesterol-dependent, actinindependent nanoclusters (Ariotti et al., 2010). Upon EGF-stimulation, EGFR clustering
and MAPK signaling increases, a process that is dependent on phospholipase D2
(PLD2)-produced PA (Ariotti et al., 2010). This work suggests EGFR signaling is
dependent on its nanocluster formation and PA-association. Similarly, TRPV4 channels
form complexes that are dependent on membrane integrity, as shear stress, the force
produced by blood flow, disrupted the clustering of TRPV4 channels (Baratchi et al.,
2017). While much is yet to be discovered about the spatial organization of
transmembrane receptors, it is a promising area of study.

1.2.3 Arf GTPases
ADP ribosylation factor (Arf) small GTPases are localized to the PM and regulate
membrane trafficking, vesicle formation, and lipid transport (Donaldson & Jackson,
2011). Arf GTPases recruit effectors to the PM and promote the formation of effector
signaling complexes on the PM (Cherfils, 2014). Interestingly, a recent study using
coarse-grained molecular dynamics simulations strongly suggests that efficient Arf
activation by its GEF, Brag2, is facilitated by local PIP2 enrichment and a distinct
orientation on the PM when in complex with one another (Karandur et al., 2017). While
it is not known whether Arf GTPases form nanoclusters like Ras, the lipid-dependency
of Arf activation suggests lipid domain assembly and phospholipid interactions play a
functional role in Arf signaling.
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1.3 Rac1 spatial regulation
Rac1’s role in regulating cytoskeletal changes leads to polarized signaling in
different cell types. For example, one study found that in response to exogenous
chemoattractant, neutrophils and fibroblasts will accumulate PIP3 in a polarized manner,
due to a positive feedback loop between Rho GTPases and PIP3 synthesis by PI3K
(Weiner et al., 2002). Incidentally, in another study from that same year, a Rac1 GEF
coined phosphatidylinositol (3,4,5)-trisphosphate dependent Rac exchange factor 1 (PRex1) was discovered to be directly and synergistically activated by PIP3 and Gbg in vivo
and in vitro (Weiner, 2002, Welch et al., 2002). These studies were some of the first to
directly associate Rac1 activity and spatial organization with PIP3. Several years later,
PIP3 was found to be essential for efficient Rac1 localization to liposome membrane,
Rac1-Rho guanine-nucleotide dissociation inhibitor (GDI) dissociation, and guanine
nucleotide exchange (Ugolev et al., 2008). RacB, a Rac-family member found in
Dictyostelium discoideum, demonstrates similar polarization and activation during
chemotaxis (Park et al., 2004).
Cell fractionation experiments and immunogold-labeling in fibroblasts reveal that
both Rac1 and RhoA exhibit polarized localization at the cell PM in actin-enriched raftdomains called caveolae (Michaely et al., 1999). Moreover, other studies conclude that
Rac1 targets cholesterol-rich lipid raft domains (del Pozo et al., 2004). More recent
reports using FRET suggest Rac1 localizes initially to cholesterol-rich domain
boundaries but prefers non-raft, cholesterol-poor regions (Moissoglu et al., 2014). While
these studies provide valuable insight about Rac1 spatial regulation, many of the
conclusions are drawn from experiments using detergents and cholesterol-depleting
agents like methyl-b-cyclodextrin. The mechanism of action for cyclodextrins is not
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completely known and their use can affect phospholipids and disrupt the boundaries of
PM domains (Zidovetzki & Levitan, 2007). Therefore, care must be taken when drawing
conclusions from their use.
Advancements in imaging techniques have enabled researchers to make more
accurate assessments about Rac1 spatial regulation (Maxwell et al., 2018). One study
shows PIP3 to be enriched in active Rac1 clusters at the leading edge (Remorino et al.,
2017). This is consistent with a previous finding that Rac1 PM interactions are PIP3dependent (Das et al., 2015). They also observe distinct mobile and immobile behaviors
of Rac1 molecules that are PIP3-dependent (Das et al., 2015). Interestingly, cryo-electron
microscopy experiments reveal activation of the WAVE regulatory complex by Rac1
requires two Rac1 proteins acting simultaneously, supporting a model by which effectors
are able to sense the local density of active Rac1 in the cell (Chen et al., 2017). These
studies reveal a higher order of Rac1 PM organization. In this study, I demonstrate the
existence of Rac1 nanoclusters in cell plasma membrane and characterize them
thoroughly and quantitatively in the following chapters.

1.4 Rac1 biology
1.4.1 Activity and effectors
Rac1 is a Rho family member of the Ras superfamily of small GTPases, all of
which broadly influence cell morphology, cell growth, and gene transcription. Rho family
members include RhoA, RhoB, RhoC, RhoE, RhoG, Cdc42, Rac2, and Rac3 (Haataja
et al., 1997, Ridley, 1996, Zhang et al., 1998). Rac1, Rac2, and Rac3 are 92%
homologous, sharing 58% amino acid sequence identity with Rho and 30% with Ras
(Didsbury et al., 1989). While Rac1 is highly expressed across all tested human tissue
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types, Rac2 and Rac3 are less highly expressed, with Rac2 primarily found in bone
marrow (hematopoietic cells), lymph nodes, spleen, and appendix, and Rac3 in testis,
brain, and fat tissue (Fagerberg et al., 2014). All GTPases are molecular switches that
cycle between an active and inactive state to signal to second messengers (Bourne et
al., 1991). This process is controlled and aided by GAPs, which promote intrinsic GTP
hydrolysis and inactivation, and GEFs, which activate the protein by accelerating
nucleotide release, promoting GDP à GTP exchange (Bos et al., 2007). Rac1’s intrinsic
ability to hydrolyze GTP is similar to other Rho family GTPases and is 10x faster than
that of Ras (Zhang et al., 1998).
Guanine-nucleotide exchange of G proteins is facilitated by a conserved “Gdomain,” specifically two regions called switch I and switch II that interact with the
guanine nucleotide and demonstrate enhanced flexibility, adopting “closed” and “open”
conformations that promote or discourage GEF/effector interaction (Vetter, 2014) (Fig.
2). The mechanism of conformational change from the GTP-bound form is thought to be
universal for most GTPases. Oxygen from the g-phosphate forms hydrogen bonds with
threonine in switch I and glycine in switch II (Vetter & Wittinghofer, 2001). Release of the
g-phosphate after hydrolysis leads the switch regions to adopt the GDP-bound
conformation, which is more divergent among GTPases than the GTP-conformation
(Vetter & Wittinghofer, 2001). Crystallization of Rac1 in complex with certain domains of
the GEF T cell lymphoma invasion and metastasis factor 1 (Tiam1) reveal switch I and II
are stabilized in conformations that disrupt Mg2+ binding and association with GDP,
illustrating how GEFs like Tiam1 encourage GTP-binding (Worthylake et al., 2000).
Rac1 is pleiotropic and interacts with a multitude of effector proteins that control
many cellular processes. Though not an exhaustive list, the following proteins are some
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of Rac1’s most prevalent effectors (Bustelo et al., 2007, Soriano-Castell et al., 2017):
Cytoskeletal –Diaph1, Diaph2, Arfip2, Baiap2, IQGAP1, IQGAP2, Was, Nck1, Nckap1,
Cyfip2, Wasf1, Wasf2, Paks1-7, Cdc42bpgA, Cdc42bpgB, Fml1, Fhod1, Cyfip1, FlnA,
TubA1 (microtubule component); Ubiquitination –Smurf2; Cell polarity –Pard6A,
Pard6B, Fml1; Immune response -IL1Rap1; Signal transduction –Cdc42SE1,
Cdc42SE2, Hspc121, PlcB2, Map3K11, PrkCA; Transcription –Fhod1, Stat3, Hspc121;
Reactive Oxygen Species (ROS) –Nos2A, CybA, Ncf1, Ncf2; Endocytosis –SynJ2,
ROCK1. The ability of Rac1 to interact with so many different proteins highlights the
evolutionary need for signaling molecules like Rac1 to form complexes and nanoclusters.

1.4.2 Trafficking to the plasma membrane
Translocation to the PM is absolutely essential for Rac1 activation and signaling.
While all Rac proteins localize to the PM, Rac2 is predominantly found in the Golgi,
endoplasmic reticulum, and nuclear envelope, and Rac3 primarily localizes to
endomembranes (Ridley, 2006, Roberts et al., 2008). Like Ras, Rac1 undergoes several
post-translational modifications on the membrane anchor of the HVR to target to the PM
(Figs. 2-3). First, geranylgeranyltransferase type 1 covalently adds a geranylgeranyl
isoprenoid chain to the cysteine residue of the CAAX motif, which is subsequently
cleaved by Rce1 (Roberts et al., 2008). The now prenylated C-terminal cysteine residue
is methylated by Icmt (Roberts et al., 2008). Like K-Ras4A and K-Ras4B, Rac1 contains
a PBD of six contiguous basic residues (Fig. 3). While biotin-BMCC experiments suggest
Rac1 is not palmitoylated on an upstream cysteine residue (Drisdel & Green, 2004,
Roberts et al., 2008), Rac1 incorporates 3[H]-palmitic acid and is mislocalized by
mutation of the cysteine residue to serine, suggesting that it likely is palmitoylated
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(Navarro-Lerida et al., 2012). This carboxy terminal membrane anchor sequence is
evolutionarily conserved in Rac1, Rac2, Rac3 and across multiple species, such as
Xenopus laevis, Canis familiaris, and Mus musculus, and all contain the putatively
palmitoylated cysteine residue upstream of a polyproline sequence and the PBD
(Roberts et al., 2008).
Another class of regulators involved in controlling Rac1 PM localization and
activation are Rho guanine-nucleotide dissociation inhibitors (GDI). As their name
suggests, these proteins inhibit guanine nucleotide dissociation from Rho-family
members and prevent their activation (Keep et al., 1997). RhoGDIs interact with the
prenyl group (largely geranylgeranyl, few Rho proteins are farnesylated, such as RhoE
(Foster et al., 1996)) through hydrophobic contacts. This interaction not only prevents
PM binding, it inhibits contact with effectors by interfering with the switch I and II regions
(DerMardirossian & Bokoch, 2005). Because PM localization is necessary for Rac1
function, the shuttling of Rac1 between PM and cytosol by RhoGDI is a major regulator
in controlling Rac1 signaling. Interestingly, there is evidence to suggest that PIP3 helps
facilitate RhoGDI dissociation from Rac1, promoting Rac1 activation (Ugolev et al.,
2008).
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LCPP PVKKKKKKCLLL
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Figure 2. Important protein domains in Rac1
Rac1 contains several regions required for effector binding, which are primarily located
in the N-terminus approximately between amino acids 25-40 (Westwick et al., 1997),
although other effector binding sites can be found toward the C-terminus (Diekmann et
al., 1995). The evolutionarily conserved G-domain of the protein contains the switch
regions, which bind to GTP/GDP and define small GTPases. Rac1 spatial organization
is primarily driven by the hypervariable region, which contains the membrane anchoring
domain. This region contains the PBD, palmitoylated residues, and CAAX motif, which
is prenylated by a geranylgeranyl chain.
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Figure 3. Lipidated membrane anchors of Ras and Rac1
Rac1 and Ras target the PM in a similar manner, through a minimal membrane anchor
in the C-terminus of the protein. Ras membrane anchors comprise a C-terminal farnesylcysteine-methyl-ester, plus dual palmitoyl lipid chains in H-Ras, a single palmitoyl in NRas and polybasic domains in K-Ras4A and K-Ras4B. Rac1 is likewise prenylated, with
geranylgeranyl at the C-terminal cysteine residue of the CAAX motif and contains both
polybasic sequence and a single palmitoyl.
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1.4.3 Actin dynamics
Rac1’s role in regulating actin dynamics was realized not long after its initial
discovery. In Swiss 3T3 cells, expression of a constitutively GTP-bound Rac1 mutant,
Rac1.G12V (amino acid 12 glycine à valine) induces the formation of membrane ruffles
and actin stress fibers and rapidly increases the amount of polymerized actin in the ruffles
(Ridley et al., 1992). Furthermore, expression of dominant-negative mutant Rac1.T17N
prevents membrane ruffling in growth-factor stimulated cells, suggesting membrane
ruffling is a direct response to actin filament formation and Rac1 is a key regulator (Ridley
et al., 1992).
Actin cytoskeletal reorganization is the driving force for cell migration, a cell
process vital to healthy tissue, but also important in the metastasis of tumors (Nobes &
Hall, 1999). Three major types of filaments are produced in a migrating cell: lamellipodia,
filopodia, and stress fibers. Lamellipoda are wide, flattened protrusions that consist of
cross-linked actin filaments (Nobes & Hall, 1999, Sit & Manser, 2011). Filopodia are
slender protrusions consisting of many, thin actin filaments (Nobes & Hall, 1999, Sit &
Manser, 2011). Both of these structures are at the leading edge of cells. Stress fibers
form further back from the leading edge. They comprise actin-myosin filaments that insert
into focal adhesion complexes and are thought to provide forward momentum for the
lagging edge as the cell migrates (Nobes & Hall, 1999, Sit & Manser, 2011, Small et al.,
1996). A detailed illustration of these structures and the signaling molecules involved can
be found in Sit & Manser, 2011. Genetic deletion of Rac1 in mice prevents lamellipodia
formation, cell adhesion, cell spreading, and stress fiber formation in fibroblasts,
supporting earlier evidence that Rac1 is a direct regulator of actin formation (Guo et al.,
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2006). These studies provide a clear connection between Rac1 activity and actin
polymerization.
Major downstream Rac1 effectors that control actin include p21-activated kinase
1 (Pak1), which phosphorylates LIM kinase (LIMK). LIMK directly phosphorylates and
inactivates cofilin, a protein that severs actin filaments thus stabilizing actin filament
formation (Spiering & Hodgson, 2011). Activation of cofilin is likewise an important
mechanism by which cells can both create and destabilize dynamic structures for
movement. Another effector is WAVE, which binds directly to Rac1 and activates the
Arp2/3 complex, which serves as a nucleation site for new actin growth and branched
actin networks (Spiering & Hodgson, 2011).
Changing actin dynamics has implications for other important cell events. For
example, Rac1-dependent actin reorganization is necessary for glucose-transporter-4
recruitment to the PM in skeletal muscle (Chiu et al., 2011). Dendritic spines, crucial
neuronal structures for learning and memory, are formed by dynamic linear and branched
filamentous actin networks that help maintain their plasticity (Dent et al., 2011). Irregular
actin polymerization contributes to disease, which is discussed more fully in Chapter 1
Section 5, Rac1 signaling in disease. Finally, actin-driven membrane ruffling precludes
macropinosome formation, a specialized type of endocytosis, which is discussed in the
following section.

1.4.4 Endocytosis
Endocytosis is an important regulatory process in which cells actively uptake
extracellular molecules against their concentration gradient. Clathrin-mediated
endocytosis is facilitated by various receptors and clathrin-coated vesicles/pits
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concentrated in the PM. Activated Rac1 inhibits transferrin-receptor mediated
endocytosis and regulates the formation of clathrin-coated vesicles (Lamaze et al., 1996,
Malcez et al., 2000), though this process does not occur through Pak1 activation
(Dharmawardhane et al., 2000). Non clathrin-mediated endocytosis includes: caveolae,
small pits in the PM enriched in cholesterol and caveolin; macropinocytosis, the
nonselective uptake of fluid from the extracellular matrix arising from invaginations of the
PM; and phagocytosis, the internalization of extracellular matter involving larger
particles.
While Rac1 signaling is important for both caveolin accumulation and
phagocytosis (Castellano et al., 2000, Nethe et al., 2010), this study focuses on
macropinocytosis. Rac1’s connection to macropinocytosis was first explored during early
experiments connecting Rac1 signaling to membrane ruffling, as macropinocytosis is
precluded by highly ruffled regions of the cell (Ridley et al., 1992). Some of these ruffles
fold back into the PM, encapsulating extracellular fluid and forming 0.2 µm diameter (or
larger) sized vesicles called macropinosomes that either recycle back to the PM, or more
frequently, fuse with lysosomes (Fujii et al., 2013). Overexpression of Rac1.G12V
induces macropinocytosis in fibroblasts (Ahram et al., 2000), while Rac1.T17N
expression inhibits macropinocytosis in dendritic cells (West et al., 2000). Additionally,
overexpression of constitutively-active Pak1 stimulates macropinocytosis while
overexpression of a Pak1 autoinhibitory domain blocks macropinocytosis, even in the
presence of growth-factor and constitutively-active Rac1 (Dharmawardhane et al., 2000).
These results provide a clear pathway between Rac1 and macropinocytosis through
Pak1 activation. Interestingly, experiments using photoactivatable-Rac1, which can be

21

both activated and deactivated, suggests Rac1 deactivation is just as important as
activation in completing macropinosome closure and endocytosis (Fujii et al., 2013).

1.4.5 Cell growth
Rac1 affects cell growth in several ways. Rac1 regulates gene expression through
the activator protein-1 (AP-1) transcription factor, which can be activated by multiple
signaling events (Bosco et al., 2009). Rac1 activates nuclear factor kappa-light-chainenhancer of activated B cells (NF-kB), c-Jun N-terminal kinase (JNK), and p38 MAPK,
which in turn activate AP-1. This activation occurs through Pak activation or
independently of Pak (Aznar & Lacal, 2001, Westwick et al., 1997). The Rac1 effector
POSH and Rac1-activated kinases MEKK4 and MLK3 have been implicated in JNK and
p38 activation (Aznar & Lacal, 2001, Gerwins et al., 1997, Tibbles et al., 1996).
Additionally, Rac1 modulates the binding of nuclear factor of activated T cells (NFAT) to
AP-1 by NFAT dephosphorylation and nuclear transport, which is required for the proper
expansion and growth of antigen-specific lymphocytes (Turner et al., 1998). Likewise,
the Rac1 GEF Vav upregulates AP-1 to induce cell proliferation in Jurkat cells
(Kaminuma et al., 2002). AP-1 upregulates the expression of cyclin D1 and c-myc, which
induce progression through G1/S transition in the cell cycle (Chiariello et al., 2001, Olson
et al., 1995).
Overexpression of dominant-negative Rac1.T17N in rat fibroblasts abrogates cell
growth and arrests cells in G2/Mitosis transition of the cell cycle, establishing that Rac1
is necessary for cell proliferation and demonstrating the importance of Rac1 signaling in
multiple stages of cell division (Moore et al., 1997). Rac1 also induces cell transformation
in NIH 3T3 cells, and downstream of K-Ras in fibroblasts and K-Ras-induced lung cancer
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in mice (Kissil et al., 2007, Westwick et al., 1997). Rac1 is critical for cell growth in cancer
cells, which is mediated in large part by NF-kB. In non-small cell lung carcinoma, siRNAsilencing and direct inhibition of Rac1 results in decreased cell proliferation and migration
(Gastonguay et al., 2012). Those cells exhibit dampened G1 progression in the cell cycle,
decreased NF-kB transcription, and cell migration (Gastonguay et al., 2012).

1.4.6 ROS
Rac1-stimulated production of reactive oxygen species (ROS) through
nicotinamide adenine dinucleotide phosphate (NADPH) is another mechanism by which
Rac1 signaling contributes to transcription factor activation, immune response,
apoptosis, cell transformation, and cell proliferation (Bosco et al., 2009). Rac1-induced
activation of NADPH oxidase produces toxic products essential for degrading bacteria in
leukocytes (Bokoch, 1995). Additionally, Rac1 contains a novel effector region (amino
acids 124-135) essential for superoxide production and mitogenesis in fibroblasts.
Removal of this effector region has no effect on membrane ruffling or JNK activation,
implicating superoxide production as a potential independent pathway for Rac1mediated cell growth (Joneson & Bar-Sagi, 1998).
NADPH oxidase activation requires the formation of a macromolecular complex
at the PM, comprising integral membrane proteins gp91phox (also called Nox2) and
p21phox and cytosolic proteins p67phox and p47phox (phox = phagocytic oxidase)
(Diekmann et al., 1994). Rac1.GTP binds directly to p67phox, the suspected effector in
the complex (Diekmann et al., 1994, Nisimoto et al., 1997). However, Rac1.GTP also
binds directly to Nox1, a homolog of gp91phox activated by Rac1 that produces ROS
(Cheng et al., 2006). Moreover, immunoprecipitation experiments show that Rac1 forms
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complexes with Nox1 and the regulatory subunits Noxo1 and Noxa1, suggesting the
NADPH-Rac1 complex is more complicated than previously thought (Cheng et al., 2006).
A more recent study has found that Rac1-ROS signaling is spatially and
temporally regulated in response to shear stress (Liu et al., 2013). Researchers
discovered the existence of a novel, sensory complex that produces ROS in response to
mechanical force on the PM. PECAM-1, an endothelial cell adhesion molecule, acts as
a mechano-sensor and leads to Vav2 activation, a Rac1 GEF (Liu et al., 2013). Vascular
endothelial-cadherin (VE-cadherin), p67phox, Tiam1, and Par3 complex with Rac1.GTP
and polarize local Rac1 signaling to stimulate ROS (Liu et al., 2013). Depletion of VEcadherin, Tiam1, or Par3 leads to reduced ROS production. These studies reinforce the
hypothesis that Rac1 clustering is necessary and functionally relevant for directed and
localized signaling.

1.5 Rac1 signaling in disease
Aberrant Rac1 signaling is involved in many different pathological conditions,
including cancer, neurodegeneration, cardiovascular disease, inflammation, the immune
response, and some kidney disorders (Marei & Malliri, 2017). Here I have detailed some
of the most important mechanisms involved in Rac1-driven diseases. Given the
complexity of Rac1 signaling and its association with both protective and malignant
effects, successful therapeutics must have the capability to selectively inhibit Rac1 in
malignant pathways, while simultaneously sparing its protective functions in other
pathways. Thus, developing novel Rac1 inhibitors requires a comprehensive
understanding of Rac1 functions within diverse cellular contexts. This study aims to
further our present understanding.
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1.5.1 Cancer
Rho family members are prominent regulators of angiogenesis, transcription, and
cell growth; through these processes, Rac1 drives cancer initiation and progression
(Benitah et al., 2004, Mack et al., 2011, Merajver & Usmani, 2005). Furthermore, Rac1
is a key metastasis driver in tumor tissue through the activation of cell motility and
invasion (Geiger & Peeper, 2009, Parri & Chiarugi, 2010, Yilmaz & Christofori, 2010).
Specifically, these processes occur when Rac1 stimulates the formation of actin-rich
protrusions like lamellipodia, focal adhesions, and cell contraction, all of which contribute
to cell migration (Miki et al., 2000, Nobes & Hall, 1995). Two major events in metastatic
progression, mesenchymal-epithelial transition and epithelial-mesenchymal transition,
are also regulated by Rac1 (Lv et al., 2013, Nakaya et al., 2004).
Rac1 protein levels are often overexpressed or overactivated in several types of
cancer. For example, Rac1 is overexpressed in stomach, breast, and testicular cancer
(Kamai et al., 2004, Pan et al., 2004, Schnelzer et al., 2000). A splice variant of Rac1,
Rac1b, is likewise overexpressed in tumors, including colorectal, breast, and lung cancer
(Jordan et al., 1999, Schnelzer et al., 2000, Zhou et al., 2013). While less is known about
Rac1b compared to Rac1, this splice variant exhibits enhanced GTP/GDP exchange and
is predominantly GTP-bound, allowing increased interaction with effectors (Schnelzer et
al., 2000). In a transgenic mouse model of sebaceous adenoma, epidermal-specific
activation of Rac1 leads to poorly-differentiated adenomas that resemble malignant
sebaceous tumors, establishing a correlation between Rac1 activity and malignant skin
tumors (Frances et al., 2015).
There are several oncogenic, activating mutations in the RAC1 gene. Rac1.P29S
mutation substitutes serine for proline in the switch I region, and is the third most
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prevalent mutation in sun-exposed melanomas (9.2%) identified by exome sequencing
after BRAF and NRAS (Krauthammer et al., 2012). Rac1.P29S is also identified in head
and neck squamous cell carcinoma and the breast cancer cell line MDA-MB-157
(Kawazu et al., 2013, Stransky et al., 2011). Rac1.P29S exhibits enhanced effector
binding due to a favorable conformational change and rapid nucleotide exchange (Davis
et al., 2012). Rac1.N92I (asparagine à isoleucine) and Rac1.C157Y (cysteine à
tyrosine) are another pair of activating mutations identified in a fibrosarcoma cell line and
a lung adenocarcinoma specimen from the COSMIC database of cancer genome
mutations, respectively (Kawazu et al., 2013). However, comparatively these mutations
are not prevalent.
Adding even greater complexity, there is evidence that Rac1 offers anti-cancer
benefits, largely through mechanisms that promote cell adhesion and hinder cell invasion
(Marei & Malliri, 2017). For example, overexpression of Rac1.G12V or Tiam1 in Rastransformed epithelial cells strengthens cadherin-mediated cell adhesion and actin
polymerization at cell-cell contacts, affecting transformation and abrogating invasiveness
(Hordijk et al., 1997). In another example, RNAi silencing of Rac-specific D4-GDI in an
invasive human breast cancer cell line paradoxically hinders tumor growth and lung
metastasis in mice by stimulating anoikis, although the mechanism of how this occurs is
not completely understood (Zhang et al., 2009).

1.5.2 Cardiovascular disease
Rac1 is involved in the development of cardiovascular disease. Transgenic mice
expressing constitutively active Rac1 exhibit cardiomyopathy (Sussman et al., 2000),
and cardiomyocyte-specific overexpression of Rac1 in mice leads to cardiac
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hypertrophy, myocardial infarctions, and increased susceptibility to ischemic injury
(Talkuder et al., 2013). Rac1 is implicated in atherosclerosis through activation of
NADPH oxidases. ROS production contributes to atherosclerotic plaque formation in vivo
(Judkins et al., 2010) and suppression of ROS production in macrophages and vessel
cells attenuates atherosclerosis. Increased endothelial permeability is one mechanism
by which atherosclerotic plaque production is encouraged; this effect is likely
downstream of Pak, as inhibition of Pak in vivo reduces endothelial permeability in
regions with high atherosclerotic plaques (Orr et al., 2007).

1.5.3 Neurodegenerative disease
Rac1 signaling is essential for neuronal development and the maintenance of
neuro-plasticity (Stankiewicz & Linseman, 2014). While Rac1 does exhibit some
neuroprotective effects against Parkinson’s and neurodegeneration, it is implicated in a
variety of neurological disorders (Marei & Malliri, 2017). Overproduction of ROS
downstream of Rac1 contributes to motor neuron degeneration in an ALS (amyotrophic
lateral sclerosis, commonly known as Lou Gherig’s disease) mouse model (Wu et al.,
2006). Rac1 is also implicated in Huntington’s disease through interactions with mutant
huntingtin (Tourette et al., 2014) and in Alzheimer’s disease, through transcriptional
regulation of an amyloid precursor protein (Wang et al., 2009). This protein generates
amyloid-b, the polypeptide that accumulates in the brain tissue of Alzheimer’s patients
(Wang et al., 2009). Increased Rac1 activity in a mouse model of Fragile X syndrome
(FXS), a disorder characterized by intellectual disabilities, inhibits cofilin, an important
regulator of dendritic spine structure. These mice also show dendritic spine abnormalities
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in the somatosensory cortex, a hallmark of FXS, as a result of the increased Rac1 activity
(Pyronneau et al., 2017).

1.5.4 Inflammation
Rac1 mediates multiple inflammatory responses. For instance, Rac1 is
overactivated in models of kidney disease and exacerbates ROS production and
inflammatory cytokines (Sedeek et al., 2013). Rac1 deletion in macrophages and
myeloid-specific Rac1 knockout in vivo protected against renal inflammation and injury
by reducing inflammatory cytokines (Nagase et al., 2016). Additionally, a Rac1 inhibitor
reduced arthritic symptoms in a mouse model of rheumatoid arthritis, implicating Rac1 in
arthritis inflammation as well (Abreu et al., 2010). Finally, increased Rac1 expression is
associated with inflammatory bowel disease and in fact, some classes of drugs used to
treat inflammatory bowel disease target Rac1 signaling (Al Hadithy et al., 2005, Muise et
al., 2011).

1.6 Drugs targeting Rac signaling pathways
Despite the difficulty in inhibiting Rac1 signaling, several compounds presently
exist that target different mechanisms of Rac1 regulation. A small molecule screen
identified NSC23766 as the first selective Rac1 inhibitor, disrupting Rac1-Tiam1
association without affecting Vav (another Rac1 GEF) function, RhoA or Cdc42 (Gao et
al., 2004). This compound exhibits anti-tumorigenic effects and prevents osteoarthritis
development in vivo, though ultimately NSC23766 is not efficacious enough for clinical
application (Bid et al., 2013, Zhu et al., 2015). Optimization of NSC23766 led to the
development of a more potent Rac1 inhibitor called EHop-016 (IC50 of 1.1 µM). This
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compound blocks Rac1-GEF binding to Vav2 as opposed to Tiam1, and suppresses cell
migration in a metastatic breast cancer cell line (Montalvo-Ortiz et al., 2012).
Other compounds interrupt nucleotide binding, such as EHT 1864, which blocks
GEF-mediated nucleotide exchange and effector binding with a fairly high potency (IC50
5 µM) (Shutes et al., 2007). Another group identified two compounds from a highthroughput screen that target the Rac1 nucleotide binding site and reduce cell
proliferation and migration in pancreatic cancer cell lines (Arnst et al., 2017). While nonselective for Rac1, there are also some compounds that target Rac1 PM localization,
such as geranylgeranyltransferase inhibitors, palmitoyl acyltransferase inhibitors, and
methylation blockers (Marei & Malliri, 2017). There are also efforts underway to identify
inhibitors of downstream targets, such as Pak or LIM kinase (Bid et al., 2013). For
example, Phox-I1 is a compound that binds to p67phox and disrupts Rac1 interaction,
leading to decreased superoxide production and inflammation (Bosco et al., 2012). 8hydroxy-2-deoxyguanosine (8-OHdG) is another molecule that blocks superoxide
production through Rac1 inhibition and provides atherosclerosis protection in vivo (Huh
et al., 2012).

1.7 Summary and experimental approach
Rac1 is an essential signaling molecule. One conspicuous example of its
importance is the result of germline deletion of RAC1, which causes embryonic death at
an early stage (Duquette & Lamarche-Vane, 2014). It is also unsurprising that mutations
or aberrations in Rac1 have disastrous consequences in cells and in the body. However,
a greater understanding is required for the development of effective clinical therapies
specifically targeting Rac1. The objective of this study is to investigate Rac1 regulatory
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mechanisms on the PM, which is the connecting point for Rac1’s diverse signaling
pathways and their attendant pathogenic manifestations. Particularly, this study aims to
expand our comprehension of how Rac1 coordinates spatially and temporally regulates
signal output in advance of other mechanisms.
Specifically, the first aim of my hypothesis is that Rac1 forms functionally-relevant
clusters on a nanoscale level with Ras. Such clusters are approximately 20 nm sized
complexes that must be visualized using high-resolution microscopy, and could form the
basis for the locally-regulated Rac1 signaling conceptualized by several studies
referenced in this chapter. The second aim of my hypothesis is that these clusters
incorporate signaling phospholipids that assist in recruiting second messengers. Finally,
the third aim of my hypothesis is that the mechanism(s) driving nanocluster formation is
key interactions between PM lipids and the membrane anchor of the Rac1 protein.
This study employs EM combined with spatial mapping analysis (described in
Chapter 2, Materials and Methods). These methods are advantageous because the
resolution of EM allows for the detection of nanoclusters between 10 and 100 nm, while
Ripley’s K function quantifies the point patterns of gold-labeled protein and lipid probes
on the PM.
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Chapter 2
Materials and Methods
2.1 Plasmids
Rac1 membrane anchor mutants were created from a green fluorescent protein
conjugated (GFP) Rac1.G12V parent vector using the QuickChange XL site directed
mutagenesis kit from Agilent and polymerase chain reaction (PCR) (Ridley et al., 1992).
Sergio Grinstein from The Hospital for Sick Children in Toronto, Canada gifted GFPLactC2. Guangwei Du from the University of Texas Health Science Center in Houston,
TX provided GFP-PASS (Zhang et al., 2014), GFP-pleckstrin homology domain (PH)phospholipase C d (PLCd), and GFP-PH-Akt. Tamas Balla from the National Institute of
Child Health and Human Development in Bethesda, MD gifted GFP-FAPP1.

2.2 Cell culture and transfection
Wild-type baby hamster kidney (BHK) cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% bovine calf serum (BCS) or simply DMEM in serumfree conditions at 37° C and 5% CO2. Cells were transfected 24-hours after plating using
Lipofectamine (Invitrogen) reagent in Optimem media for 4-6 hours and replaced with
regular DMEM after Lipofectamine incubation. Cells were fixed 24-hours posttransfection as applicable for the experiment. PIP3 levels were manipulated by treating
cells for 1 hour with 15 μM PI3K inhibitor LY294002 (Sigma-Aldrich). PIP3 levels were
rescued by co-treating cells with 15 μM LY294002 and 10 μM exogenous 18:0-20:4 PIP3
(Avanti Polar Lipids) or elevated with just supplemental PIP3. PA levels were manipulated
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using 0.5 μM phospholipase D (PLD)-2 specific inhibitor ML298 (Sigma-Aldrich). PA
levels were rescued by co-treating cells with ML298 and 10 μM egg PA (Avanti Polar
Lipids), or elevated with just supplemental PA. When the experiment called for PIP2
manipulation, PIP2 levels were elevated by co-treating cells with LY294002 and 10 μM
brain L-a-PIP2 (Avanti Polar Lipids). Non water-soluble compounds were dissolved in
dimethyl sulfoxide (DMSO), which was also used to treat control cells.

2.3 Western blotting
BHK cells expressing GFP-tagged Rac1 mutant constructs were grown to confluence
and harvested. Cells were washed twice with ice cold phosphate buffered saline (PBS)
followed by 5-minute incubation in 100 µL lysis buffer containing: 1% NP40, 50 mM Tris
(pH 7.5), 25 mM NaF, 75 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 0.5 µg/mL aprotinin, 0.1
mM Na3VO4, 3 µg/mL leupeptin, and 1 mM DTT. Cell lysates were centrifuged at 1000
RPM at 4°C for 5 minutes. The concentration of total protein was measured and taken
from the supernatant. 20 µg of total protein was mixed with sample buffer (10 mM Tris
(pH6.8), 20 mg/mL SDS, 10% glycerol, 0.5 mg/mL bromophenol blue dye and 15.4
mg/mL DTT), heated at 95°C for 5 minutes, and resolved by electrophoresis in 12% SDSpolyacrylamide gel. Proteins were electro-transferred to polyvinylidene difluoride (PVDF)
membrane using pre-chilled transfer buffer (3.6 mg/mL glycine, 7.25 mg/mL Tris base,
0.46 mg/mL SDS, 20% methanol). PVDF membranes were rinsed 3x with TBST (10 mM
Tris (pH 7.5), 150 mM NaCl, 0.1% Tween 20) and blocked for 1 hour in 5% skim milk in
TBST. Primary antibody labeling was performed overnight by inoculating the PVDF
membrane in blocking solution containing primary antibody: anti-GFP at 1:3000 dilution
and anti-actin at 1:1000. PVDF membranes were washed 3x in TBST and incubated for
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1 hour with secondary antibody in blocking solution (anti-rabbit at 1:2000, anti-mouse at
1:8000). PVDF membranes were washed 3x with TBST again and incubated with
enhanced chemiluminescence (ECL) solution: 2 mL SuperSignal West Pico stable
peroxide solution and 2 mL SuperSignal West Dura stable peroxide solution.

2.4 Electron Microscopy and spatial mapping analysis
2.4.1 Univariate K-function
This technique quantifies clustering of a single population on the inner leaflet of the cell
plasma membrane (Prior et al., 2003) and has been described previously (Hancock &
Prior, 2005, Zhou et al., 2014, Zhou et al., 2017). BHK cells were seeded on glass
coverslips at ~75% confluency on day one and transiently transfected with GFP-tagged
protein or peptide on day two. On day three, after any experimental treatment, intact
apical PM sheets were attached to EM grids, washed, fixed (4% paraformaldehyde/0.1%
glutaraldehyde), labeled with 4.5 nm gold particles conjugated to anti-GFP antibody, and
embedded in uranyl acetate. Pictures of the PM sheets were obtained using a JEOL
JEM-1400 transmission EM at x100,000 magnification (Fig. 4). From these images, 1
μm2 regions were selected and each gold particle on the region was assigned x and y
coordinates using ImageJ. The gold particle distribution and extent of nanoclustering was
calculated using Ripley’s K function, as shown in the following equations:
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whereby K(r) is the univariate K function for a pattern of n points in area A; r is the radius
at which K(r) is calculated (length scale = 1 < r < 240 nm at 1-nm increments); ||xi – xj||
is Euclidean distance; 1((xi –xj|| ≤ r) is the indicator function with a value of 1 if ||xi – xj|| ≤
r and a value of 0 otherwise; wij-1 is the proportion of the circumference of the circle with
center xi and radius ||xi – xj|| contained within A. L(r)–r is a linear transformation of K(r)
and standardized on the 99% confidence interval (C.I.) estimated from Monte Carlo
simulations. Under the null hypothesis of complete spatial randomness, L(r)–r has an
expected value of 0 for all values of r. Positive deviations of the function from the
confidence interval indicate significant clustering. For each condition in this study, 10-30
PM sheets were collected and analyzed. Bootstrap tests were used to determine
statistical differences between replicates and significance was evaluated against 1,000
Bootstrap samples. A useful summary statistic for L(r)–r values is Lmax, the peak value
from the K function curve. All statistical differences between Lmax values were determined
by Bootstrap evaluation of their corresponding weighted mean L(r)–r values.

2.4.2 Bivariate K-function
This technique is prepared similarly to univariate K function analysis, but uses BHK cells
co-expressing two different proteins or peptides tagged with GFP or red fluorescent
protein (RFP) (Prior et al., 2003, Zhou et al., 2014, Zhou et al., 2017). After fixation, PM
sheets were labeled with 2 nm gold conjugated to anti-RFP antibody and 6 nm gold
conjugated to anti-GFP antibody and embedded in uranyl acetate (Fig. 5). The gold
particle distributions were analyzed using a bivariate K function that calculates coclustering or co-localization of the two different gold particle populations on a PM sheet:
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whereby Kbiv(r) comprises two bivariate K functions. Kbs(r) characterizes large (6 nm)
gold particle distribution with respect to each small gold particle and Ksb(r) characterizes
small (2 nm) gold particle distribution with respect to each large gold particle. Area A
contains nb, number of large gold particles, and ns, number of small gold particles.
Remaining notations are the same as equations [1-2]. Lbiv(r)–r is a linear transformation
of Kbiv(r) and normalized against the 95% C.I. from Monte Carlo simulations. Under the
null hypothesis of no spatial interaction between the two gold populations, Lbiv(r)–r has
an expected value of 0 for all values of r. Positive deviations of Lbiv(r)–r from the C.I.
indicate significant co-clustering between the two gold populations. A useful summary
statistic to quantify the extent of co-clustering is the area under the Lbiv(r)–r curve over a
fixed range (10 < r < 110 nm) which is termed Lbiv(r)–r integrated, or LBI, defined as:

𝐿𝐵𝐼 =
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𝑆𝑡𝑑
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For each condition, 10-30 PM sheets were imaged, analyzed, and averaged. LBI values
> 100 (95% C.I.) indicate significant co-clustering. Statistical significance between
bivariate point patterns is determined using Bootstrap tests as in 2.4.1 Univariate Kfunction. All statistical differences between LBI values were determined by Bootstrap
evaluation of their corresponding weighted mean Lbiv(r)–r values.
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2.5 Fluorescence lifetime imaging microscopy (FLIM)
combined with fluorescence resonance energy transfer
(FRET)
FRET occurs when an excited, donor fluorophore transfers energy to an acceptor
fluorophore within range of a given distance, approximately 10 nm or less. FLIM
measures the lifetime of the fluorophore signal as opposed to intensity, which offers the
advantage of independence from excitation source and fluorophore concentration. When
combined with FRET, this method provides information about the association between
two molecular probes. A lower lifetime of the signal represents an increase in FRET, or
association, between two fluorophores. FLIM-FRET assays were performed as
described previously (Zhou et al., 2013, Zhou et al., 2017). BHK cells were grown to 70%
confluency on glass coverslips and transiently transfected with both GFP-tagged and
RFP-tagged proteins. Cells were washed with 1X PBS and fixed in 4%
paraformaldehyde. Lifetime measurements were measured with a FLIM unit from
Lambert Instruments (Roden, the Netherlands) mounted on a wide-field Nikon Eclipse
microscope. GFP was excited using a sinusoidally stimulated 3-watt 497-nm LED at 40
MHz under epifluorescence coupled with a 60X Plan-Apo/1.4-NA oil immersion lens.
FRET efficiency, defined as [1 –(acceptor lifetime ÷ donor lifetime)], was calculated from
the FRET lifetime values, which were averaged from 3 independent experiments and at
least 120 different cells. FRET efficiency denotes the percentage of excitation photons
that contribute to FRET. A higher efficiency value indicates an increase in FRET.
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2.6 Macropinocytosis
The quantification of macropinocytosis was performed as described previously
(Commisso et al., 2014). In brief, BHK cells expressing GFP-tagged Rac1 mutant
constructs or GFP-pC1 (empty vector) were serum-starved overnight, fixed, and treated
with DMEM + 1 mg/mL 70 kDa tetramethylrhodamine (TMR)-conjugated dextran.
Approximately 10-20 fields per sample were taken on a Zeiss Axiovert inverted 200M
wide-field microscope equipped with a 63X 1.4 NA phase objective lens and CCD
camera. Using ImageJ, the total area of macropinosomes was divided by total cell area
(x100), giving the macropinocytic index as an indictaor of dextran uptake and
macropinocytosis. Data averaged from 3 separate experiments and approximately 250
cells.

2.7 Cell spreading
BHK cells expressing Rac1 mutant constructs from the macropinocytosis assay were
also utilized to calculate cell spreading. Cell area per field was measured using ImageJ
and divided by the number of cells as an indicator of cell spreading. The results were
averaged across all sample images (Wurtzel et al., 2012).

2.8 Statistical analysis and graphics
Data are expressed as means ± standard error (SEM) and statistical significance of
differences were determined using Student’s unpaired t tests, one-way ANOVA followed
by Tukey HSD (honest significant difference) post hoc test, or Bootstrap tests.
Differences were considered significant when p-values were below 0.05. Illustrations
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were made in Microsoft PowerPoint. Graphs were prepared using Graphpad Prism,
Microsoft PowerPoint, Microsoft Excel, and Adobe Illustrator.

2.9 Limitations
A major limitation of the study is the use of overexpression. Overexpression of GFP- and
RFP-tagged constructs is required to visualize the constructs by the microscopy methods
used herein, though the disadvantage is that expression levels of the proteins and probes
are no longer physiological. At best, the constructs are a reflection of endogenous protein
behavior but not definitively so. Furthermore, the lipid binding probes used to identify
specific lipids bind to head groups, and cannot distinguish between different lipid species
with the same head group. For example, the degree of saturation of hydrophobic chains
can differ between two of the same lipid. The advantage of overexpression is that it
ensures a robust signal, and care was taken with each experiment to include both
positive and negative controls. Additionally, the monomeric form of GFP was used in all
cases, preventing noncovalent GFP dimerization.
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Chapter 3
Rac1 nanoclustering
3.1 Introduction
Similar to other Rho-family members, like RhoA and Cdc42, Rac1 is spatially and
precisely coordinated on the PM to regulate cytoskeletal events (Kraynov et al., 2000,
Machacek et al., 2009, Ridley et al., 2003). Rac1 signaling is compartmentalized to the
PM, where it interacts with effector proteins, such as WAVE, and GEFs and GAPs, such
as Tiam1, to coordinate actin dynamics and facilitate membrane ruffling (Chen et al.,
2017, Wertheimer et al., 2012). Rac1 signaling is further regulated by RhoGDI, which
solubilizes cytosolic Rac1.GDP from the PM to abrogate the coordinated efforts of PMmediated signal output (Bustelo et al., 2011).
Rac1 may be spatially organized in oligomers on the PM to coordinate signaling.
Recent findings show that Rac1 is distributed in a gradient from the leading edge of cells
with phospholipids (Das et al., 2015). These gradients suggest a heterogeneous
distribution of Rac1 on the PM, and provide greater insight to earlier studies showing
Rac1 and RhoA distributions are polarized (Michaely et al., 1999). Another study
validates this finding, and further establishes that Rac1 forms oligomers of approximately
200 nm on the PM that precede WAVE and PIP3 PM association (Remorino et al., 2017).
Details of Rac1 oligomer structures are still not known. I hypothesize that Rac1
may form smaller nanoclusters, like Ras, which are approximately 16 nm in diameter
rather than 200 nm, due to the similarities in the membrane anchor and PM binding
between Rac1 and Ras isoforms. The minimal Ras membrane anchors comprise a C-
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terminal farnesyl-cysteine-methyl-ester, plus dual palmitoyl lipid chains in H-Ras, a single
palmitoyl in N-Ras and a polybasic domain in K-Ras. Rac1 is also prenylated, with
geranylgeranyl at the C-terminal cysteine residue of the CAAX motif and contains both
polybasic sequence and a single palmitoyl (Fig. 3).
In this chapter, I systematically examine the propensity for Rac1 to form
nanoclusters using EM, and find that Rac1 forms nanoclusters that are approximately 20
nm in diameter and spatially segregate on guanine nucleotide binding. These findings
suggest a higher level of regulation of Rac1 on the PM than previously realized.

3.2 Results
3.2.1 Rac1 localizes to the PM and forms nanoclusters
It is well established that Rac1 localizes to the PM for its function. To verify that
the Rac1 constructs used in this study properly target to the PM in BHK cells, I ectopically
expressed GFP-tagged Rac1.WT (wild-type), Rac1.G12V (constitutively active, GTPbound), and Rac1.T17N (dominant-negative, GDP-bound) in BHK cells and imaged the
cells using confocal microscopy. I found that regardless of GTP-binding, all the
constructs localized to the PM and were thus suitable for EM imaging and analysis (Fig.
6).
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Figure 6. Rac1 localizes to the plasma membrane in BHK cells
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To examine Rac1 spatial organization on the PM, I used EM combined with spatial
mapping analysis. Intact 2D PM sheets of BHK cells expressing GFP-Rac1.G12V
(sample image in Fig. 4) were attached to EM grids and immunolabeled with 4.5 nm antiGFP gold antibody. The spatial distribution of the gold particles was quantified using
univariate K functions and plotted as L(r)–r (Fig. 7A). L(r)–r values above the 99%
confidence interval (C.I.) indicate statistically significant clustering at length scale r. We
used the peak L(r)–r value, called Lmax, to summarize the results. The Lmax value for
Rac1.G12V was similar to Lmax observed for Ras (Fig. 7B). Additionally, I measured the
nanoclustering of GFP-tagged Rac1.WT, Rac1.G12V, and Rac1.T17N. The extent of
gold labeling of each Rac1 protein was similar, indicating equal PM localization,
concordant with the confocal images (Fig. 8A). Constitutively-GTP bound Rac1.G12V,
constitutively-GDP bound Rac1.T17N, and Rac1.WT all showed significant Lmax values
above the confidence interval, indicating that Rac1.GDP and Rac1.GTP both form
nanoclusters on the PM (Fig. 8B). Rac1.G12V Lmax values from several different
univariate EM experiments were plotted against corresponding gold particle number to
demonstrate the quantitative independence of clustering and PM localization for Rac1 at
the standard level of expression for all EM experiments (Fig. 9).
Ras proteins have a monomer to cluster ratio of approximately 20-30% (Plowman
et al., 2005). To determine an estimate of the amount Rac1 proteins in the nanoclusters,
I calculated the average percent of gold particles that exist as monomers (1 particle),
‘dimers’ (2 particles), or oligomers (3+ particles) for every PM sheet. Rac1.WT and
Rac1.T17N exhibit a similar monomer to cluster ratio as K-Ras4B, while Rac1.G12V has
a slightly higher population of oligomers (Fig. 10). It should be noted that the presence
of gold particle ‘dimers’ in this instance is not indicative of a structural dimer interaction,
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given that some non-gold-labeled GFP or endogenous Rac1 could interact in

Supplemental Figure 1

clusters/dimers with the gold-labeled Rac1 and would not be detected by EM.
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Figure 8. Rac1.GTP and Rac1.GDP form nanoclusters on the plasma membrane
A. PM sheets taken from BHK cells expressing GFP-tagged Rac1.WT, Rac1.G12V, and
Rac1.T17N were fixed and prepared as described for univariate EM. The number of gold
particles per µm2 was counted and averaged as an indicator of PM localization for each
mutant. Data averaged from at least 20 different cells. Statistical significance of
differences between groups was determined using Student’s t tests and no significant
differences were measured. B. The same PM sheets as described in (A) were analyzed
using univariate K functions to quantify the extent of Rac1 nanoclustering. The data were
averaged and summarized as Lmax ± SEM. Statistical significance of differences between
groups was determined using Bootstrap tests. No significant differences were found
between groups.
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Mean Lmax ± SEM values of Rac1.G12V from different univariate EM experiments were
plotted against gold particle number per µm2 to demonstrate the independence of
clustering with respect to gold particle labeling, within the typical experimental range of
100-700 gold particles per PM sheet. Data averaged from 15-20 different cells for each
experiment.
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PM sheets taken from BHK cells expressing GFP-tagged K-Ras4B.G12V, Rac1.WT,
Rac1.G12V, and Rac1.T17N were fixed and prepared as described for univariate EM.
The gold particle population for each protein was analyzed and summarized into the
distribution of monomers, dimers (2 gold particles/cluster), and oligomers (3+ gold
particles/cluster). Data averaged from at least 12 different cells.

3.2.2 Rac1 nanoclusters are spatially segregated by nucleotide
binding
Ras proteins spatially segregate upon guanine nucleotide binding, such that
Ras.GDP and Ras.GTP nanoclusters are non-overlapping (Abankwa et al., 2007,
Plowman et al., 2008). In this way, effectors are more efficiently targeted to regions of
activated Ras on the PM to propagate signaling, while GAPs can be more effectively
localized as well to attenuate the signal. To determine whether Rac1 displays similar
behavior, I analyzed the co-localization, or co-clustering, between Rac1.GTP and
Rac1.GDP proteins. Intact PM sheets of BHK cells co-expressing GFP-Rac1.G12V and
RFP-Rac1.T17N were serum-starved, attached to EM grids, and immunolabeled with 6
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nm anti-GFP and 2 nm anti-RFP gold antibody (Fig. 5). Co-localization between the two
populations of gold was quantified using bivariate K functions plotted as Lbiv(r)–r against
radius size r (Fig. 11A). Lbiv(r)–r values above the 95% C.I. indicate significant colocalization. As a summary statistic, we used an integration of the bivariate K function
curves termed Lbiv-integrated (LBI) (Zhou et al., 2014). LBI values above 100 indicate
statistically significant co-localization and the greater the LBI value, the greater the extent
of co-localization between the two populations. The LBI value for GFP-Rac1.G12V and
RFP-Rac1.G12V indicated significant co-clustering at 176.58 ± 20.18, consistent with
significant Lmax values for univariate Rac1.G12V clustering (Fig. 11B). As another
positive control, GFP-Rac1.WT and RFP-Rac1.T17N showed significant co-localization.
LBI values for GFP-Rac1.G12V and RFP-Rac1.T17N, and GFP-Rac1.G12V and RFPRac1.WT were both below the C.I. of 100, indicating efficient spatial segregation between
GTP-bound Rac1 and GDP-bound Rac1 (Fig. 11B). These results indicate Rac1 forms
spatially segregated nanoclusters in a guanine nucleotide dependent fashion.
To validate the EM results, I used FLIM-FRET to assess global co-localization
between Rac1.GDP and Rac1.GTP in BHK cells. The data were summarized as FRET
efficiency (%) between the GFP and RFP fluorophores as described in the methods.
Lower FRET efficiency indicates lower FRET, or association, between GFP and RFP.
FRET efficiency between GFP-Rac1.G12V and RFP-Rac1.G12V was similar to GFPRac1.T17N and RFP-Rac1.WT, and significantly higher than FRET efficiency for GFPRac1.G12V

and

RFP-Rac1.T17N

and

corroborating the EM results (Fig. 11 C-D).
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Figure 11. Rac1 forms spatially segregated nanoclusters
A. PM sheets prepared from BHK cells co-expressing GFP-Rac1.G12V and RFPRac1.T17N were serum-starved, fixed, and prepared as described for bivariate EM and
analyzed using bivariate K functions. Plots of the weighted mean standardized bivariate
K functions are shown. 95% C.I. is the 95% confidence interval for a random pattern.
Lbiv(r)–r values derived from Ripley’s K function above the confidence interval denote
significant co-clustering of two populations. Data averaged from at least 20 different cells.
B. PM sheets prepared from BHK cells co-expressing GFP- and RFP-Rac1 constructs
were fixed and prepared as described for bivariate EM and analyzed using bivariate K
functions to quantify the extent of co-clustering. The data were averaged and
summarized as LBI ± SEM. Data averaged from at least 15-20 different cells. Statistical
significance of differences betwen groups was determined using Bootstrap tests (*p <
0.001). C. BHK cells co-expressing GFP- and RFP-Rac1 constucts were serum starved,
fixed, and imaged by FLIM-FRET. The data were averaged and summarized as FRET
Efficiency (%) ± SEM from GFP lifetime values (ns). Data averaged from at least 120
different cells. Statistical significance of differences between averages of the original
lifetime values was determined using one-way ANOVA followed by Tukey HSD post hoc
test (*p < 0.01) D. Representative images from the FLIM experiment in (C).
49

3.3 Discussion
I found that Rac1 forms nanoclusters that are segregated depending on their
activation state. In this regard, Rac1 shows similarity to Ras nanoclusters, which are
isoform and guanine-nucleotide selective (Abankwa et al., 2007, Hancock & Parton,
2005). Ras nanoclusters are essential for downstream Ras signaling, and provide a
mechanism by which Ras isoform-selective signaling output is generated, as Ras
nanoclusters segregate by isoform-type as well as GTP-binding (Hancock, 2003). This
isoform-specific selectivity is driven in part by the ability of Ras clusters to sort different
PM phospholipids and recruit effectors. Rac1 nanoclusters may regulate Rac1 signaling
in the same way. In this regard, I hypothesize that Rac1.GTP clusters act as signaling
sites for effector binding and recruitment. By selectively sorting specific PM lipids,
Rac1.GTP clusters may be able to attract GEFs, GAPs, and effector proteins with
maximal efficiency. The ability of Rac1 nanoclusters to selectively sort phospholipids is
explored in Chapter 4, Lipid-dependency of Rac1 nanoclusters.
Rac1 spatial organization has been studied before. As referenced previously in
this chapter, SPT data shows that Rac1 is distributed in ~200 nm sized nanoclusters that
are spatially distributed from the leading edge of cells in tandem with PIP3 (Remorino et
al., 2017). One possibility that corroborates this finding with my results is that smaller
Rac1 nanoclusters are being recruited into larger oligomers when enclosed by the
formation of ruffles and localized PIP3 in a ruffling cell or during macropinocytosis. This
possibility is reinforced by work showing that PIP3 distributes in gradients that correlate
with Rac1 distributions (Das et al., 2015). Additionally, Rac1 molecules diffusing laterally
on the PM separate into two populations with fast and very slow diffusion rates (Das et
al., 2015). I postulate this dynamic behavior reflects Rac1 proteins that are freely
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diffusing as monomers and Rac1 proteins confined to nanoclusters. A similar integration
of EM spatial mapping data with SPT data suggests that Ras proteins may be transiently
confined in immobile nanoclusters or diffuse freely, supporting this idea (Hancock &
Parton, 2005, Murakoshi et al., 2004).
My discoveries using high-resolution EM demonstrate that Rac1 is spatially
organized on a nanoscale level. This level of organization could promote more direct
interactions with phospholipids that may be crucial for Rac1 signaling. The biological
relevance of these clusters, what lipids they incorporate, and what protein domains drive
the clustering are topics that are explored in the following chapters.
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Chapter 4
Lipid-dependency of Rac1 nanoclusters
4.1 Introduction
Rac1 interactions with PM lipids are critical for Rac1 lateral diffusion, building on
earlier work suggesting that Rac1 spatial organization and function are dependent on
lipid lateral heterogeneity within the PM (Moissoglu et al., 2014). Specifically, PA is
necessary for the recruitment of Tiam1 to the PM and downstream membrane ruffling
(Bohdanowicz et al., 2013). PIP3 is associated with Rac1 activation by correlative
analyses (Das et al., 2015, Remorino et al., 2017) and through activation of the GEF PRex1 (Welch et al., 2002). Why these particular lipids are important for Rac1 signaling is
not understood. In context of the findings in Chapter 3, Rac1 nanoclustering, I
hypothesize that Rac1.GTP nanoclusters selectively sort anionic phospholipids in a
manner that is similar to Ras proteins, which form nanoclusters that comprise their own
distinct lipid compositions, which in turn modulate effector recruitment and drive isoformselective downstream signaling (Hancock, 2003, Zhou et al., 2014). For example, Ras
nanoclusters selectively sort phospholipids and K-Ras clusters are structurally
dependent on PtdSer (Cho et al., 2012, Cho et al., 2015, Zhou et al., 2014). Removing
PtdSer from the inner leaflet of the PM mislocalizes K-Ras from the PM, disrupts
clustering, and stops MAPK signaling. As Ras nanoclusters are the sole sites for
Raf/MEK/ERK recruitment and activation, disrupting the nanoclusters has consequences
for signal output (Tian et al., 2007).
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I find that Rac1 nanoclusters similarly have a distinct lipid composition which
potentially contributes to effector binding and downstream signaling. In this chapter, I use
bivariate EM to determine the extent of co-clustering between Rac1 and different lipid
probes and compare these results to previously quantified co-localization values
between Ras isoforms and lipid probes (Zhou et al., 2014). Additionally, I explore the role
phospholipids play in Rac1 clustering based on these data by manipulating the
availability of specific lipids on the inner leaflet of the PM. These findings provide insight
as to how PA and PIP3 contribute to Rac1 signaling.

4.2 Results
4.2.1 Rac1 nanoclusters selectively associate with PA and PIP3
To determine whether Rac1 associates with specific PM phospholipids and
whether Rac1 nanoclusters have a distinct lipid composition, I performed a series of
bivariate EM co-localization assays between Rac1 and different lipid probes. Intact PM
sheets of BHK cells dually expressing RFP-tagged Rac1 constructs (Rac1.GTP or
Rac1.GDP) and GFP-tagged lipid probes were attached to EM grids. GFP and RFP were
labeled with 6 nm and 2 nm gold, respectively. LBI values to quantify the extent of coclustering were calculated and arrayed in a heat map (Fig. 12, Table 1), whereby red
represents high LBI and blue represents low LBI values below the confidence interval.
As shown in the heat map, both Rac1.GTP and Rac1.GDP nanoclusters were enriched
with PA and PIP3, demonstrated by high LBI values with the PA and PIP3 lipid probes.
The extent of co-clustering between K-Ras4B.GTP, H-Ras.GTP, and H-Ras.GDP and
the lipid probes was consistent with previously performed co-clustering experiments (Fig.
12) (Zhou et al., 2014). Like K-Ras4B, the K-Ras4A.GTP splice variant showed high co53

localization with phosphatidylserine (PtdSer), consistent with previous work showing KRas4A is sensitive to fendiline, a PtdSer depleting agent (Cho et al., 2015). The lipid
composition of N-Ras nanoclusters had not been previously examined. I found that NRas.GDP clusters prefer cholesterol while N-Ras.GTP nanoclusters prefer PIP3 (Fig.
12). It is not known whether PIP3 directly regulates N-Ras signaling, though PI3K is a
major Ras-effector (Castellano & Downward, 2011), and previous work suggests that NRas is sensitive to cholesterol depletion and localizes to raft-domains in the PM (Roy et
al.,

2005).

Interestingly,

microdomain

targeting

seems

to

be

a

membrane

anchor/palmitoyl-driven event, as monopalmitoylation of H-Ras at C181, the same as NRas, is sufficient to emulate N-Ras membrane behavior (Roy et al., 2005).
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Lmax

PM sheets prepared from BHK600
cells co-expressing GFP-tagged lipid binding probes and
RFP-protein constructs (G12V or WT) were fixed and prepared as described for bivariate
EM. The resulting LBI values400
for co-clustering between the probe and protein were
2
arrayed in a heatmap and binned by lipid-type. LBI values above the 95% confidence
200 significant co-localization between protein and lipid
interval (100, white) demonstrate
(red), while values below the confidence interval show spatial segregation (blue). Data
0
0
averaged from at least 15 cells. Lipid binding probes: PS, LactC2; PI(4,5)P2, PH-PLC𝛿;
Rac1
PIP
H-Ras
Rac1
3 PH-2FYVE.
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Table 1. LBI values for co-clustering between lipid binding probes and Rac1/Ras
PM sheets prepared from BHK cells co-expressing GFP-tagged lipid binding probes and
RFP-protein constructs (G12V or WT) were fixed and prepared as described for bivariate
EM. Resulting LBI values from Fig. 12 are presented here. LBI values above 100
represent significant co-clustering between lipid and protein. Data averaged from at least
15 cells. Lipid binding probes: PS, LactC2; PIP2, PH-PLC𝛿; PI4P, FAPP1; cholesterol
(chol.), D4; PIP3, PH-Akt; PA, PASS; PI3P, PH-2FYVE.
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4.2.2 PA is a key structural component of Rac1 nanoclusters
To validate the finding that Rac1 nanoclusters are enriched with PA, I acutely
depleted endogenous PA and measured changes in Rac1 clustering. BHK cells
expressing the PA-probe (GFP-PASS) were treated for 1 hour with 0.5 µM ML298, a
specific inhibitor of phospholipase D2 (PLD2), which catalyzes the conversion of PA from
phosphatidylcholine (PC). Treatment with ML298 significantly decreased the amount of
gold labeling for PA, indicating that PLD2 inhibition effectively depleted endogenous PA
from the inner leaflet of the PM (Fig. 13A). ML298 treatment significantly mislocalized
Rac1.G12V from the PM and disrupted the nanoclustering of Rac1.G12V remaining on
the PM in BHK cells ectopically expressing GFP-Rac1.G12V (Fig. 13).
To further validate PA involvement in Rac1 cluster formation, BHK cells
expressing the PA-probe or Rac1.G12V were treated with ML298 and supplemented with
10 µM exogenous PA. PA was incorporated into the inner leaflet of the PM, because
control experiments with the PA probe showed that supplemental PA restored PA levels
to the inner leaflet of the PM in the presence of ML298 (Fig. 13A). N-Ras nanoclusters
were not enriched with PA (Fig. 12, Table 1), and ML298 had no effect on N-Ras PM
localization or clustering (Fig. 13).
I hypothesized that Rac1’s sensitivity to ML298 arises from Rac1 co-clustering
with PLD2 on the PM. Using bivariate EM to test the co-localization between PLD2 and
Rac1.G12V in the presence of ML298, I found that ML298 treatment had no effect on the
co-localization between Rac1.G12V and PLD2. However, the compound did disrupt the
association between Rac1.G12V and the PA probe (Fig. 14). This result suggests that
disrupted clustering induced by ML298 is a result of PA loss and not mislocalization of
PLD2.
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4.2.3 PIP3 is a key structural component of Rac1 nanoclusters
Additionally, I hypothesized that Rac1 nanoclusters would show a similar
dependency to PIP3 as PA. I acutely depleted endogenous PIP3 and measured changes
in Rac1 clustering. BHK cells expressing the PIP3-probe (GFP-PH-Akt) were treated for
1 hour with 15 µM LY294002 (LY294), a specific inhibitor of phosphoinositide 3-kinase
(PI3K), which catalyzes the conversion of PIP3 from phosphoinositol (4,5)-bisphosphate
(PIP2). Treatment with LY294 significantly decreased the amount of gold labeling for
PIP3, indicating that PI3K inhibition effectively depleted endogenous PIP3 from the inner
leaflet of the PM (Fig. 15A). LY294 treatment significantly mislocalized Rac1.G12V from
the PM and disrupted the nanoclustering of Rac1.G12V remaining on the PM in cells
expressing GFP-Rac1.G12V (Fig. 15). H-Ras nanoclusters do not contain a significant
amount of PIP3 (Fig. 12, Table 1), and LY294 had no effect on H-Ras PM localization
and clustering (Fig. 15). In lipid addback experiments, supplementing LY294 treated
cells with exogenous PIP3 and the PIP3-precursor PIP2 effectively rescued the PM
localization and clustering of Rac1, suggesting that PIP2 add-back was able to overcome
the inhibition of PI3K (Fig. 15). PIP3 added to the outer leaflet of the PM is delivered to
the inner leaflet because control experiments showed adding supplemental PIP3 to BHK
cells significantly enhanced gold-labeling of the PIP3 probe on the inner leaflet (Fig. 15A).
To distinguish potential roles of PA vs. PIP3 in mediating Rac1 clustering, I
performed cross supplementation experiments. As Fig.13A showed, adding back
exogenous PIP3 in the presence of the PA-depleting ML298 did not rescue the
nanoclustering of GFP-Rac1.G12V. Further, adding PA did not rescue the clustering of
Rac1 with LY294002 treatment (Fig. 15B). These data suggest that PA is sufficient for
Rac1 PM localization, but both PA and PIP3 are necessary for nanocluster formation.
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H-Ras.G12V were fixed and prepared as described for univariate EM. Cells were treated
for 1 hour with 15 μM phosphoinositide 3-kinase (PI3K) inhibitor LY294002 (LY294),
DMEM supplemented with 10 μM exogenous PIP3, LY294 + DMEM supplemented with
10 μM exogenous PIP3, LY294 + DMEM supplemented with 10 μM exogenous PA,
LY294 + DMEM supplemented with 10 μM exogenous PIP2, or DMSO. The number of
gold particles per μm2 were counted and averaged as an indictaor of PM localization for
each construct. Data averaged from 12-20 different cells. Statistical significance of
differences between treatment groups and DMSO for each construct was determined
using Student’s t tests (*p < 0.05, **p < 0.003). B. The same PM sheets described in (A)
were analyzed using univariate K functions to quantify the extent of Rac1 and H-Ras
clustering. The data were averaged and summarized as Lmax ± SEM. Statistical
significance of differences between treatment groups and DMSO for each construct was
determined using Bootstrap tests (*p < 0.02, **p < 0.004).
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4.2.4 Rac1 is insensitive to PtdSer-depletion
Unlike the K-Ras splice variants, Rac1 did not associate with PtdSer (Fig. 12,
Table 1). To reinforce the notion that Rac1 association with PA and PIP3 is structurally
relevant, I depleted PtdSer from the PM using 15 µM fendiline, an acid sphingomyelinase
inhibitor that disrupts the synthesis of PtdSer and mislocalizes K-Ras from the PM (Cho
et al., 2015, van der Hoeven et al., 2013). Fendiline treatment had no effect on the PM
localization or nanoclustering of Rac1.G12V or Rac1.WT (Fig. 16). This result provided
further support that the lipid composition of nanoclusters is specific and necessary for
the nanoclustering of its protein constituents.
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Figure 16. Rac1 nanoclusters are insensitive to PtdSer-depletion
A. PM sheets taken from BHK cells expressing GFP-tagged Rac1.G12V and Rac1.WT
were fixed and prepared as described for univarate EM. Cells were treated for 1 hour
with 15 μM fendiline or DMSO. The number of gold particles per μm2 were counted and
averaged as an indictaor of PM localization. Data averaged from 12-20 different cells.
Statistical significance of differences between treatment groups for each construct was
determined using Student’s t tests. No significant differences were seen between
treatment groups. B. The same PM sheets described in (A) were analyzed using
univariate K functions to quantify the extent of Rac1 clustering in the presence or
absence of fendiline. Statistical significance of differences between treatment groups for
each construct was determined using Bootstrap tests. No significant differences were
found between treatment groups.
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4.3 Discussion
In this chapter, I systematically examine the lipid composition of Rac1
nanoclusters. Rac1 nanoclusters have a distinct lipid composition from previously
characterized Ras, selectively associating with PA and PIP3 over PtdSer, PIP2,
cholesterol, and other anionic phospholipids. This capacity to interact with PA and PIP3
is biologically relevant because depleting the PM of PA or PIP3 decreases Rac1 PM
binding and reduces the nanoclustering of Rac1 remaining on the PM. In turn, Rac1 does
not show selectivity for PtdSer and is insensitive to disruption of PtdSer synthesis. Rac1
nanoclusters are therefore structurally dependent on PA and PIP3, with lipid addback
experiments further indicating that PA and PIP3 are both necessary but not individually
sufficient for nanocluster formation. Interestingly, PIP2 rescues Rac1 nanoclustering and
PM localization after PIP3-depletion, suggesting that sustained PIP3 synthesis from PIP2
is able to overcome the inhibition of PI3K. This result indicates that local generation of
PIP3 at the nanocluster sites strengthens Rac1 clustering and PM localization. Though
Rac1 shows significant co-clustering with PLD2, suggesting the PA found in Rac1
nanoclusters is locally generated, it is not known whether PC, the precursor for PLD2generated PA, is able to rescue Rac1 clustering and PM localization in the absence of
PA.
As referenced previously, other studies link PM lipids to Rac1 function. For
example, PA is required for membrane ruffling and macropinocytosis through recruitment
of Tiam1 to the PM (Bohdanowicz et al., 2013). Similarly, PIP3 is required for the
activation of P-Rex1 and is correlated with localized Rac1 activation in the leading edge
of migrating cells (Das et al., 2015, Remorino et al., 2017, Weiner, 2002). The results
presented here yield new mechanistic insight to this biology by demonstrating that the
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Rac1 anchor encodes binding specificity for PA and PIP3, which results in the formation
of nanoclusters enriched in these anionic lipids. Taken together, these studies along with
my findings presented here suggest that Rac1 nanoclusters act as lipid based signaling
platforms for efficient effector binding and recruitment, emulating the spatiotemporal
organization of Ras proteins (Zhou & Hancock, 2017, Zhou & Hancock, 2015, Zhou et
al., 2017). The basis for this anionic lipid specificity and its functional relevance is a topic
that is explored in detail in Chapter 5, Rac1 nanoclustering and lipid specificity is
determined by a prenyl-PBD code.

Destabilization
of Rac1.G12V
nanoclusters

Rac1.GDP
Rac1.GTP
PA
PIP3

Figure 17. Model of Rac1 nanoclusters
Illustration depicting Rac1 nanocluster formation and sensitivity to phospholipid
manipulation on the PM. Rac1.GDP nanoclusters are represented in blue and Rac1.GTP
nanoclusters are represented in red. PM lipids incorporated in Rac1 nanoclusters (PA
and PIP3) are colored green and turquoise. PM lipids not associated with Rac1 are not
represented in the model. Depleting PA with ML298 (PLD2 inhibitor) or depleting PIP3
with LY294002 (PI3K inhibitor) destabilizes Rac1 nanocluster formation and results in
decreased clustering of Rac1.GTP.
64

Chapter 5
Rac1 nanoclustering and lipid specificity is
determined by a prenyl-PBD code
5.1 Introduction
Co-localization

analysis

from

Chapter

4,

Lipid-dependency

of

Rac1

nanoclusters shows that Rac1 nanoclusters are enriched in PA and PIP3 and depend
on these lipids specifically to properly maintain the oligomer structure. In this chapter, I
show that the capacity for distinct lipid sorting is driven by complex interactions between
the Rac1 C-terminal lipid-anchored PBD and PM lipids. In turn, Rac1 nanocluster
formation and lipid sorting directly correlate with the ability of cells to undergo
macropinocytosis and facilitate cell spreading. Macropinocytosis and cell spreading rely
on coordinated and dynamic actin networks on the plasma membrane to occur.
The membrane anchor of Rac1 comprises a geranylgeranylated C-terminal CAAX
motif, an additional palmitoyl lipid, and a PBD (Fig. 3). In this regard, Rac1 resembles
Ras proteins, which target the PM in a similar manner. Specifically, K-Ras4B and KRas4A both contain polybasic sequences similar to Rac1 that contribute to electrostatic
interaction with anionic PM phospholipids, such as PtdSer. Rac1 PBD is necessary for
membrane targeting, and effector interactions, and it is thought that the PBD interacts
globally with the PM (Lam & Hordijk, 2013, van Hennik et al., 2003). Interestingly, recent
findings show that the K-Ras4B PBD exhibits a specificity for PM lipids that cannot be
explained by simple electrostatic interactions, but originates in the specific sequence of
residues of the PBD (Zhou et al., 2017). I hypothesize that this may be similar to the
Rac1 PBD and seek to determine the exact membrane anchor residues that drive lipid
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interactions as well as Rac1 domain assembly. Furthermore, in order to test the
hypothesis that Rac1 nanoclusters are important for signal output, I explore the effects
of disrupted clustering on macropinocytosis and cell spreading, two cell processes that
are driven by Rac1 signaling (Bohdanowicz et al., 2013, Masters et al., 2013, Wurtzel et
al., 2012).

5.2 Results
5.2.1 Rac1 clustering and PM localization is dependent on
palmitoylation, prenylation, and Arginine 185
To explore the role of the membrane anchor in facilitating nanoclustering, I
generated a series of point mutations in the membrane anchoring domain of GFPRac1.G12V, represented in Figure 18. Each residue of the PBD, residues 183-188
(KKRKRK),

was

consecutively

Rac1.G12V.K183Q,

mutated

to

GFP-Rac1.G12V.K184Q,

neutral

glutamine

(Q):

GFP-Rac1.G12V.R185Q,

GFPGFP-

Rac1.G12V.K186Q, GFP-Rac1.G12V.R187Q, GFP-Rac1.G12V.K188Q. To explore
differences between arginine and lysine, both arginine residues were mutated to lysine
to

generate

a

hexa-lysine

PBD

identical

to

that

of

K-Ras4B:

GFP-

Rac1.G12V.R185K.R187K. Arginine (Arg) 185 was also changed to lysine: GFPRac1.G12V.R185K. To examine potential functions of the lipid anchors, I generated
several mutants that are not lipidated properly: GFP-Rac1.G12V.C178S and GFPRac1.G12V.C178A can no longer be palmitoylated at cysteine (Cys) 178; GFPRac1.G12V.SAAX

is

no

longer

prenylated

at

the

CAAX

box;

GFP-

Rac1.G12V.C178S.SAAX removes all palmitoylation and prenylation; and GFP-
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Rac1.G12V.CVLS contains an identical CAAX box to H-Ras that is farnesylated instead
of geranylgeranylated. Hereafter, these mutants will be denoted by their membrane
anchor mutation, i.e. GFP-Rac1.G12V.CVLS is Rac1.CVLS, or CVLS. The parent
construct from which all the mutants were generated is used as a control and is denoted
Rac1.G12V or simply G12V.
Intact PM sheets from BHK cells ectopically expressing these mutants were fixed
and analyzed by univariate EM. Western blots confirmed high expression of these
mutants in BHK cells (Fig. 19). Rac1.C178S, which is no longer palmitoylated, was
mislocalized from the PM (Fig. 20A). Rac1.C178A mirrored this result, suggesting the
mislocalization of the palmitoyl mutant was not due to possible phosphorylation of the
serine residue (Fig. 20A). Rac1.SAAX was likewise mislocalized, due to the loss of
geranylgeranylation (Choy et al., 1999, Navarro-Lerida et al., 2012). Rac1.C178S.SAAX
supported this result, which exhibited similar PM binding to Rac1.SAAX (Fig. 20A).
Interestingly, Rac1.CVLS presented significantly enhanced PM binding, suggesting a
potential difference between farnesylation and geranylgeranylation (Fig. 20A). All of the
lipidation mutants showed significant decreases in clustering compared to Rac1.G12V
(Fig. 20B).
Of the sequential PBD mutants that contain a basic à neutral residue switch, only
Rac1.R185Q showed impaired clustering (Fig. 20B). The hexa-lysine PBD mutant
Rac1.R185K.R187K showed significantly decreased clustering compared to Rac1.G12V
but displayed no change in PM localization (Fig. 20). Because of the phenotype
presented by the R185Q mutant, I hypothesized the discrepancy in R185.R187K
clustering was caused by Arg 185 rather than Arg 187. I tested the single Rac1.R185K
mutant to see if it could phenocopy the hexa-lysine phenotype. I found that to be the case
as

Rac1.R185K

exhibited

similar

PM
67

binding

and

clustering

compared

to

Rac1.R185K.R187K (Fig. 20). These data show that the amino acid sequence of the
Rac1 PBD drives Rac1 spatial distribution on the PM. It also highlights Arg 185 as a
critical residue in the hypervariable region.
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Figure 18. Sequences of Rac1 membrane anchor mutants
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Figure 19. Rac1 membrane anchor mutants are highly expressed in BHK cells
BHK cells ectopically expressing GFP-tagged Rac1 mutant constructs were harvested
and blotted for anti-GFP and anti-actin antibodies as described in the methods. All of the
cells showed high expression of the mutant constructs.
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Figure 20. Mutations in the membrane anchor of Rac1 disrupt clustering and
plasma membrane localization
A. PM sheets taken from BHK cells expressing GFP-tagged Rac1 mutants (Fig. 18) were
fixed and prepared for univariate EM. The number of gold particles per μm2 was counted
and averaged as an indictaor of PM localization for each mutant. Data averaged from
15-20 cells. Statistical significance of differences between the mutants and G12V-control
was determined using Student’s t tests (*p < 0.005). B. The same PM sheets from (A)
were analyzed using univariate K functions to quantify the extent of clustering for the
mutant Rac1 constructs. The data were averaged and summarized as Lmax ± SEM.
Statistical significance of differences between the mutants and G12V-control was
determined using Bootstrap tests (*p < 0.005).
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5.2.2 Palmitoylation, geranylgeranylation, and Arg 185 determine
PA/PIP3 association
The difference in nanoclustering between the different Rac1 PBD mutants
potentially arises from the distinct abilities of individual PBD residues to associate with
PM lipids. To test this hypothesis, I performed another set of lipid mapping analysis
similar to Figure 12 and arrayed the LBI values in a heat map. Average LBI values for
each condition are detailed in Table 2. Rac1 membrane anchor mutants that
demonstrated both impaired clustering and PM localization (C178S, R185Q) had
impaired association with both PA and PIP3, and no attendant increase in PIP2 or PtdSer
(Fig. 21). The CVLS mutant showed impaired co-localization with PA and PIP3 and
enhanced association with PtdSer (Fig. 21). Interestingly, R185K showed impaired PAassociation but maintained association with PIP3, while R185K.R187K demonstrated
impaired PIP3 association and maintained association with PA (Fig. 21). These results
imply that the Rac1 PBD sequence encodes lipid binding specificity for PA and PIP3,
which is essential for spatial organization and PM binding.
As a proof of concept, I added back exogenous PIP3 or PA to Rac1.R185K.R187K
and Rac1.R185K, respectively, to see if the lipids were able to rescue the decreased
clustering phenotype. I found that was indeed the case, as adding exogenous lipid was
able to rescue the clustering of these mutants and in fact even enhanced their PM
localization due to these mutants demonstrating no PM loss to begin with (Fig. 22).
Additionally, to test whether Rac1.CVLS gained sensitivity to PtdSer, I treated BHK cells
expressing Rac1.CVLS for 1 hour with 15 µM fendiline and found that while the
Rac1.CVLS mutant did not show a decrease in clustering in the presence of fendiline,
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Figure 21. Rac1 membrane anchor mutants lose association with PA and/or PIP3
PM sheets prepared from BHK cells co-expressing GFP-Rac1 mutant membrane anchor
constructs and RFP-tagged lipid binding probes were fixed and prepared as described
for bivariate EM. The resulting LBI values for co-clustering between the probe and protein
were arrayed in a heatmap and binned by lipid-type. LBI values above the 95%
confidence interval (100, white) demonstrate significant co-localization between protein
and lipid (red), while values below the confidence interval show spatial segregation
(blue). Data averaged from at least 15 different cells. Lipid binding probes: PS, LactC2;
PIP2, PH-PLC𝛿; PI4P, FAPP1; cholesterol, D4; PIP3, PH-Akt; PA, PASS; PI3P, PH2FYVE.

72

PA

G12V

C178S

CVLS

R185Q

R185K

R185K
R187K

LBI

138.37

56.26

95.73
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LBI

106.00

71.28

46.91

32.08

76.31

98.11

SEM

40.51

20.87

23.09

19.02

30.27

26.66

Table 2. LBI values for co-clustering between lipid binding probes and Rac1
membrane anchor mutants
PM sheets prepared from BHK cells co-expressing GFP-tagged Rac1 mutant membrane
anchor constructs and RFP-tagged lipid binding probes were fixed and prepared as
described for bivariate EM. Resulting LBI values from Fig. 21 are presented here. LBI
values above 100 represent significant co-clustering between lipid and protein. Data
averaged from at least 15 cells. Lipid binding probes: PS, LactC2; PIP2, PH-PLC𝛿; PIP3,
PH-Akt; PA, PASS.
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Figure 22. Plasma membrane localization of Rac1.R185K and Rac1.R185K.R187K
Figure
22. PM are
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and
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A. PM sheets taken from BHK cells expressing GFP-tagged Rac1 PBD mutants (Fig.
18) were fixed and prepared for univariate EM. Cells were supplemented for 1 hour with
DMEM ± 10 μM exogenous PA or PIP3 as indicated. The number of gold particles per
μm2 was counted and averaged as an indictaor of PM localization for each mutant. Data
averaged from 12-20 cells. Statistical significance of differences between treatment
groups was determined using Student’s t tests (*p < 0.05). B. The same PM sheets from
(A) were analyzed using univariate K functions to quantify the extent of clustering for the
mutant Rac1 constructs. The data were averaged and summarized as Lmax ± SEM.
Statistical significance of differences between treatment groups was determined using
Bootstrap tests (*p < 0.001).
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Figure 23. Rac1.CVLS PM localization is sensitive to PtdSer depletion
A. PM sheets taken from BHK cells expressing GFP-tagged Rac1.G12V, Rac1.CVLS,
or K-Ras.G12V (4B-splice variant) were fixed and prepared for univariate EM. Cells were
treated for 1 hour with 15 μM fendiline or DMSO. The number of gold particles per μm2
was counted and averaged as an indictaor of PM localization for each construct. Data
averaged from 10-20 cells. Statistical significance of differences between treatment
groups for each construct was determined using Student’s t tests (*p < 0.05). B. The
same PM sheets from (A) were analyzed using univariate K functions to quantify the
extent of clustering for the constructs. The data were averaged and summarized as Lmax
± SEM. Statistical significance of differences between treatment groups for each
construct was determined using Bootstrap tests (*p < 0.001).
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5.2.3 Loss of Rac1 clustering impairs macropinocytosis and cell
spreading
To explore the functional relevance of Rac1 nanoclusters, I measured the
macropinocytic index of BHK cells expressing several of the Rac1 membrane anchor
mutants. BHK cells expressing GFP-tagged pC1 (empty vector), Rac1.G12V,
Rac1.C178S, Rac1.SAAX, Rac1.R185Q, Rac1.R185K, and Rac1.K186Q were serumstarved overnight and incubated with tetramethylrhodamine (TMR)-conjugated dextran
before fixation (Fig. 24). The amount of dextran taken in by the cells through
macropinocytosis was quantified and represented as the macropinocytic index, as
described in Chapter 2, Materials and Methods. BHK expressing the pC1 empty vector
had a macropinocytic index of 88.2 ± 10.1, while ectopic expression of Rac1.G12V
significantly increased the macropinocytic index to 200.0 ± 17.1 (Fig. 25). Rac1 lipidation
and PBD mutants, C178S, SAAX, R185Q, and R185K, all yielded significantly lower
macropinocytic index values when expressed in BHK cells compared to cells expressing
Rac1.G12V (Fig. 25). The K186Q mutant, which did not have an effect on PM localization
and clustering, did not alter the macropinocytic index when expressed in BHK cells (Fig.
25).
Rac1 additionally drives cell spreading (Wurtzel et al., 2012). To determine
whether expression of these mutants influences cell spreading, I calculated the average
surface area of BHK cells expressing the GFP-Rac1 membrane anchor mutants from the
macropinocytosis assay in Figure 25. Rac1.G12V markedly enhanced the surface area
of BHK cells (Fig. 26). Closely emulating the macropinocytosis results, each membrane
anchor mutant that compromised nanoclustering also significantly affected the ability of
cells to induce cell spreading (Fig. 26). In conclusion, each mutant with impaired
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clustering exhibited a reduced ability to undergo macropinocytosis or drive cell
spreading, suggesting that Rac1 nanoclustering is necessary for downstream Rac1
signaling.

Figure 24. Expression of Rac1 membrane anchor mutants impairs dextran
uptake in BHK cells
BHK cells expressing GFP-tagged Rac1 mutant constructs or GFP-pC1 (empty vector)
were serum-starved overnight, fixed, and treated with media + 1 mg/mL 70 kDa
tetramethylrhodamine (TMR)-conjugated dextran. Representative sample images are
shown in the GFP and rhodamine channels to visualize the protein or dextran-labeled
macropinosomes, respectively. Images were processed in ImageJ and those featuring
macropinosomes were brightened for visualization purposes.
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Figure 25. Expression of Rac1 membrane anchor mutants impairs
macropinocytosis in BHK cells
BHK cells expressing GFP-tagged Rac1 mutant constructs or GFP-pC1 (empty vector)
were serum-starved overnight, fixed, and treated with media + 1 mg/mL 70 kDa
tetramethylrhodamine (TMR)-conjugated dextran. The total area of macropinosomes
was divided by cell area and multiplied x 102, giving the macropinocytic index as an
indictaor of dextran uptake and macropinocytosis. Data averaged from 3 separate
experiments and approximately 250 cells. Statistical significance of differences between
Rac1 mutants and G12V-control was determined using Student’s t tests (*p < 0.02, ***p
< 1x10-6).
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Figure 26. Expression of Rac1 membrane anchor mutants impairs cell spreading
in BHK cells
Cell spreading was quantified by using data from the macropinocytosis assay performed
previously (Fig. 25). Cell area was divided by the total number of cells, giving an average
estimate for cell spreading per cell. Statistical significance of differences between Rac1
mutants and G12V-control was determined using Student’s t tests (*p < 0.001, **p <
1x10-4, ***p < 1x10-6).
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5.3 Discussion
In Chapter 4, Lipid-dependency of Rac1 nanoclusters, I explore the concept
that Rac1 nanoclusters selectively sort PM phospholipids. Several lines of data indicate
the basis for the anionic lipid specificity is encoded in the Rac1 C-terminal membrane
anchor. Mutating arginine to lysine in the PBD, while maintaining the same net positive
charge of the PBD, generates nanoclusters with different lipid compositions than Rac1
with a wild-type PBD (KKRKRK). For example, R185K shows reduced PA association
while R185K.R187K loses PIP3 association. The R185Q mutant displays a reduction in
both PA and PIP3 sorting, suggesting Arg185 plays a critical role in defining Rac1 PM
lipid interactions. Switching the prenyl group from geranylgeranyl to farnesyl also
changes Rac1 lipid composition, promoting selective association with PtdSer rather than
PA or PIP3. This association promotes the Rac1.CVLS mutant to gain a sensitivity to
PtdSer depletion, resulting in mislocalization upon fendiline treatment. Likewise, losing
palmitoyl from the membrane anchor reduces selectivity for PA and PIP3, signifying that
both the prenyl and palmitoyl chains are important for membrane affinity. These results
suggest Rac1 interactions with membrane lipids are not simply governed by
electrostatics. Rather, the membrane anchor of Rac1 comprises a prenyl-PBD code, in
which the basic residues, arginine and lysine are non-equivalent and the length of the
prenyl chain modifies the lipid binding specificity of the core PBD. This is similar to KRas4B, where specificity for PtdSer is encoded in a polylysine-farnesyl membrane
anchor (Zhou et al., 2017), which is realized by distinct conformational structural
dynamics of the anchor that favor interactions with PtdSer head groups (Zhou et al.,
2017). Similarly, the Arf GEF Brag2 exhibits anionic lipid binding specificity for PIP2
through a polybasic domain that adopts defined conformational orientations (Karandur
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et al., 2017, Zhou & Hancock, 2017). I speculate the Rac1 anchor also adopts a defined
structure or structures on the PM that results in selective interactions of side chains on
the specific sequence of lysine and arginine in the PBD with PA and PIP3 anionic lipid
head groups. This hypothesis is supported by supplemental lipid addback experiments
that show PA and PIP3 are able to restore the clustering of Rac1.R185K and
Rac1.R185K.R187K, respectively.
Each Rac1 membrane anchor mutant exhibits different extents of PM localization
and nanoclustering and results in nanoclusters with different lipid compositions, likely
reflecting distinct lipid binding specificities. The combined effect of these changes is
reduced macropinocytosis and cell spreading compared to Rac1.G12V control,
indicating a critical role for anchor lipid binding specificity in governing effector
recruitment and Rac1 signal output. Dissecting out the relative importance of spatial
organization and PM localization to Rac1 function is more difficult. Loss of palmitate or
geranylgeranyl from the anchor or mutating R185àQ reduces both PM localization and
nanoclustering, resulting in decreased macropinocytosis and cell spreading. By contrast,
mutating R185àK has no effect on PM localization but diminishes clustering and impairs
signal output. These results implicate nanocluster formation and lipid sorting as
necessary steps for efficient downstream signaling.
As mentioned previously, PA is required for membrane ruffling and
macropinocytosis through Tiam1 (Bohdanowicz et al., 2013), and PIP3 is required for the
activation of P-Rex1 and spatially-activated Rac1 (Das et al., 2015, Remorino et al.,
2017, Weiner, 2002). The results presented in Chapter 5 yield new mechanistic insight
to this biology by demonstrating that the Rac1 anchor encodes binding specificity for PA
and PIP3, which results in the formation of nanoclusters enriched in these anionic lipids.
Taken together, these studies suggest that Rac1 nanoclusters act as lipid based
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signaling platforms for efficient effector binding and recruitment, emulating the
spatiotemporal organization of Ras proteins (Zhou & Hancock, 2017, Zhou & Hancock,
2015, Zhou et al., 2017). More broadly, the results show that the PBD-prenyl anchors of
small GTPases such as K-Ras4B and Rac1 are non-equivalent and have biological
functions that extend beyond simple electrostatic engagement with the PM.
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Chapter 6
Discussion and Future Directions

In this study, I provide evidence that Rac1 forms lipid-dependent, spatially
segregated nanoclusters on the PM that are biologically significant. I determine that
specific residues in the Rac1 PBD, in combination with the adjacent lipid anchors, govern
selective lipid sorting, which drives nanoclustering. All of these characteristics are
biologically necessary; changing the PBD amino acid sequence, removing the adjacent
lipid anchors, or depleting PM lipids they interact with blocks Rac1 clustering and has
biological consequences.
Most small GTPases are lipid-anchored and associate with bio-membranes for
their biological functions. The most studied small GTPases in terms of membrane
interactions are Ras proteins. Ras nanoclustering is mostly driven by the complex
interactions between their C-terminal membrane-anchoring domains and the polar
constituents in the PM (Abankwa et al., 2010, Prior et al., 2003). Like other PM-targeted
small GTPases, Rac1 targets the PM through its membrane anchor, containing a
palmitoyl chain conjugated to Cys178, a contiguous polybasic domain (KKRKRK, amino
acids 183-188), and a C-terminal geranylgeranyl carboxyl ester conjugated to Cys189.
This is very similar to Ras C-terminal membrane-anchoring domains, especially that of
K-Ras4B (henceforth referred to as K-Ras in this chapter), which contains a hexa-lysine
polybasic domain (Lys175-180) and an adjacent farnesyl carboxyl ester conjugated to
Cys185. Thus, it makes sense that Rac1 undergoes similar nano-spatial segregation on
the PM. Indeed, like Ras, Rac1 forms nanoclusters which spatially segregate in a
GTP/GDP-specific manner.
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Recent evidence shows that Rac1 forms large-scale nano-domains in the
lamellipodia of migrating cells in conjunction with lipid gradients (Remorino et al., 2017).
Previous studies build support for the hypothesis that domain assembly is a necessary
precursor to efficient effector binding and recruitment (Bohdanowicz et al., 2013, Das et
al., 2015, Knaus et al., 1998, Ugolev et al., 2008). This thesis provides strong evidence
that Rac1 nanoclusters act as signaling platforms for effector binding and recruitment.
By disrupting the ability of Rac1 to properly associate with PA or PIP3 through membrane
anchor manipulation, we disrupt efficient nanocluster formation and see a subsequent
impairment in macropinocytosis and cell spreading. We establish a connection between
nanocluster formation and Rac1 biological function that has not been previously
experimentally determined. This work provides insight into how Rac1 is regulated and
organized on the plasma membrane at the molecular level. These findings have
therapeutic implications. As highlighted in Chapter 1, Section 6, Drugs targeting Rac
signaling pathways, finding direct and selective inhibitors of Rac1-mediated signaling
has proved challenging, especially those that target particular signaling pathways while
leaving others unaffected. Rac1 nanoclusters and associated phospholipids could now
be used as a novel drug target for the development of new compounds.

6.1 The role of lipids
PM lipids are important signaling components and have been well established as
important structural components of Ras nanoclusters. K-Ras nanoclusters are
specifically dependent on PtdSer. Disrupting the availability of this lipid, through fendiline,
staurosporine, or other acid sphingomyelinase inhibitors, specifically abrogates K-Ras
signaling and the proliferation of K-Ras mutant expressing tumor cell lines (Cho et al.,
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2015, van der Hoeven et al., 2017, van der Hoeven et al., 2013, Zhou et al., 2015). PM
lipids also modulate actin dynamics, GEF recruitment, and regulate Rho-mediated
signaling (Baumgart et al., 2011, Bohdanowicz et al., 2013, Ugolev et al., 2008).
Six key findings lay the foundation for the discoveries and conclusions made over
the course of this project. (1) PIP3 is first identified as an important regulator of Rac1
function though the discovery of a PIP3-activated GEF, P-Rex1 (Welch et al., 2002). (2)
Highlighting the importance of phosphoinositide spatial organization in actin dynamics,
PIP2 conversion to PIP3 in membrane ruffles is found to be critical for macropinosome
formation and closure (Araki et al., 2007). (3) Several years later, in vitro studies using
synthetic liposomes reveal that PIP3 is essential for Rac1 localization to liposome
membrane, RhoGDI dissociation, and GDP to GTP exchange (Ugolev et al., 2008). (4)
Another study shows that PA is necessary for membrane ruffling and macropinocytosis
in macrophages and that both PIP3 and PA are necessary for PM recruitment of Tiam1,
but make no mention of Rac1 PM localization (Bohdanowicz et al., 2013). (5) Later work
establishes that PIP3 is distributed in a gradient that is highly correlated with Rac1
distribution (Das et al., 2015). (6) Finally, SPT-photoactivated localization microscopy
experiments show that Rac1 is distributed in 100-200 nm sized clusters that are
correlated with PIP3, Tiam1, and WAVE localization on the PM (Remorino et al., 2017).
My findings show that Rac1 nanoclusters are much smaller and are dependent on
PIP3 and PA, providing a structural mechanism for why these lipids are important for
Rac1 assembly and signaling. Local pools of PIP3 and PA are necessary for Rac1
nanoscale organization. Similarly, specific residues in the membrane anchor of the
protein drive Rac1 association with PA/PIP3 that in turn mediate clustering. Modifying
residue sequences important for phospholipid interactions disrupts nanoclustering of
active-Rac1 and, in consequence, macropinocytosis and cell spreading are interrupted,
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two cellular functions dependent on Rac1 activity. A simplified model of Rac1 nanocluster
formation based on these findings is depicted in Fig. 27.
Targeting Rac1 nanoclusters via lipid modulation could be a method to selectively
hinder Rac1 signaling without affecting RhoA or Cdc42. In another way, this method
might allow for selective blocking of certain effectors and GEFs. Changing the lipid
content on the PM could affect Rac1-phospholipid interactions and clustering in distinct
ways, preventing some GEF and effector interactions while allowing others to occur.
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6.2 Mechanistic insights
Traditionally, polybasic regions have mainly been thought to be a sensor for global
electrostatics on the PM. In other words, association between a PBD and bio-membranes
is dependent on the total number of basic residues in the PBD. However, current studies
show that K-Ras PBD, which contains a farnesylated contiguous hexa-lysine PBD,
samples various conformational orientations on the PM (Prakash et al., 2016). This
conformational folding allows the K-Ras PBD to form a pseudo-helical structure on the
PM. This means that different lysine residues have previously unrealized roles in
interacting with PM lipids, and the amino acid sequence of the PBD determines selective
lipid sorting. Indeed, each lysine in the K-Ras PBD demonstrates the distinct ability to
select various lipids in the PM (Zhou et al., 2017). The Rac1 PBD shows similar behavior,
thus possessing the capability to encompass a distinct lipid composition.
My EM lipid mapping demonstrates that Rac1 selectively co-localizes with
phospholipids. Further, single-point mutations of the Rac1 PBD have distinct clustering
abilities. Specifically, only the R185Q mutant shows impaired clustering, while the other
PBD single-point mutants cluster as efficiently as Rac1.G12V. This is also very similar to
K-Ras PBD, where only mutants K177Q and K178Q show impaired clustering (Zhou et
al., 2017). This is closely correlated with the ability of Lys177 and Lys178 to specifically
sort PtdSer. K-Ras K177Q or K178Q mutants lose association with PtdSer but become
enriched with PIP2 (Zhou et al., 2017). Because of the low levels of PIP2 in the inner
leaflet of the PM, K-Ras K177Q or K178Q mutants are markedly mislocalized from the
PM and show impaired clustering on the PM. Similarly, Rac1.R185Q loses the ability to
specifically sort PA and PIP3, which leads to compromised clustering and PM binding.
This view is further supported by the data that show RàK Rac1 mutants also cluster less
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efficiently but are rescued by exogenous PA and PIP3, suggesting that specific
conformation of the Rac1 PBD is key to Rac1 selective lipid sorting.
Interestingly, changing the prenyl group of Rac1 from geranylgeranyl to farnesyl
results in impaired clustering and increased PM binding. This mutation likewise disrupts
the lipid composition of Rac1 nanoclusters and shows enhanced PtdSer association,
suggesting the Rac1.CVLS mutant is no longer efficiently targeted to Rac1 clusters. This
result indicates that farnesyl and geranylgeranyl are not equivalent in the membrane
anchor. The increased PM binding suggests that Rac1 association with RhoGDI is
potentially interrupted, as the geranylgeranyl moiety is important for RhoGDI binding
(Keep et al., 1997). However, RhoE, RhoB, and RhoD are all farnesylated, and it is
unclear how differing prenyl groups affect RhoGDI binding across Rho family members
(Hoffman & Cerione, 2000-2013). Rac1 farnesylation has been explored before. In a
previous study, farnesylated-Rac1 retains the ability to activate c-Jun, transform cells,
and mediate membrane ruffling (Joyce & Cox, 2003). Farnesylated-Rac1 also rescues
cell spreading and ruffling inhibited by geranylgeranyl-transferase inhibition, though it is
not known whether Rac1 can be farnesylated in vivo in the absence of a functioning
geranylgeranyltransferase (Joyce & Cox, 2003). While I did not test the functional
consequences of Rac1.CVLS expression in this study, I found that Rac1.CVLS switches
its lipid preference to PtdSer, resulting in PM mislocalization when exposed to fendiline.
However, fendiline treatment does not affect clustering of Rac1.CVLS. This finding
suggests that some Rac1.CVLS proteins are localizing to Ras-associated nanoclusters
enriched in PtdSer, but some may retain association with Rac1 nanoclusters or exist as
monomers. The loss of PtdSer causes mislocalization of PtdSer-associated Rac1.CVLS
proteins, but does not affect the population of Rac1.CVLS on the PM that is not PtdSerassociated. Whether the Rac1.CVLS mutant has decreased signaling capacity or
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effector binding compared to Rac1.G12V (or in the presence of fendiline) will be an
interesting avenue of exploration going forward.
Ultimately, the consequence of membrane anchor mutation and the attendant loss
of clustering is likely the loss of second messenger signaling and recruitment via
phospholipids. For example, the Rac1 PBD is important for binding to its effectors, such
as protein kinase C-related kinase 1 (PRK1) and phosphatidylinositol 4,5-phosphate
kinase (PIP5K) (Modha et al., 2008, van Hennik et al., 2003), and PA is sufficient to
induce Pak1 autophosphorylation in vitro (Bokoch et al., 1998). Furthermore, Pak1
contains a small PBD of three adjacent lysines (K66-K67-K68) that are important for
Rac1 binding and Pak activation. Mutating the lysines to neutral residues decreases
Rac1’s ability to bind and activate Pak1, while mutating the lysines to arginines has no
effect (Knaus et al., 1998). This Pak-PBD could potentially mediate Pak1 PM targeting
and phospholipid interactions in Rac1-enriched areas. Based on my findings, I predict
that the Rac1 membrane anchor drives recruitment of local pools of phospholipids, which
in turn recruit second messengers to active-Rac1 cluster sites. This work provides a link
between phospholipids and Rac1 signaling: the formation of small-scale nanoclusters
that spatially organize second messengers to regulate signal output and mediate actindependent cellular processes such as macropinocytosis and cell spreading.

6.3 Future directions and remaining questions
While this work quantitatively expands on the spatial organization of Rac1, many
questions remain. First, how do nanoclusters recruit second messengers? One
hypothesis is that different effectors, GEFs, and GAPs target different clusters, but how
that could occur is likewise a mystery. Are there different pools of PA and PIP3 that help
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recruit specific effectors, and how are those interactions distinguished by the membrane
anchor? Additionally, is there competition between second messengers at Rac1
nanoclusters due to restrictions on cluster size or other biological factors? Likewise, does
the Pak1 PBD encode any lipid binding specificity similar to PBDs in K-Ras and Rac1?
Second, are there other residues in the membrane anchor that are important for
Rac1 spatial organization and signaling? In addition to the polybasic sequence, Rac1
contains a conspicuous tri-proline sequence directly adjacent to palmitoylated Cys178.
Sequences with contiguous prolines can form unique structures called ‘polyproline
helices,’ and efforts are underway to try and determine the functional role(s) of these
evolutionarily conserved sequences (Morgan & Rubenstein, 2013). One study found that
removal of the polyproline region, or replacement with contiguous alanines, has no effect
on PM localization (Das et al., 2015). However, as I demonstrate in this thesis, individual
residues can have a great impact on phospholipid selectivity and clustering independent
of PM localization. It would be interesting to see how changing the polyproline sequence
affects clustering, phospholipid interactions, and effector binding/activation.
Third, does the Rac1 PBD demonstrate second messenger or phospholipid
selectivity outside the context of the PM? Interestingly, evidence suggests that the PBD
encodes a nuclear localization sequence and mediates Rac1 proteasomal degradation
(Lanning et al., 2004). Whether specific residues in the PBD mediate these processes
and how those changes affect protein-protein interactions along the way is a fascinating
area of exploration.
Fourth, how do the Rac1 membrane anchor mutations explored in this study
directly affect downstream signaling and effector binding? Are there conformational
changes that occur when the protein is no longer associating with the correct
phospholipids, and/or are there interactions between Rac1 proteins that are now
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disrupted? An appropriate analogy is how K-Ras adopts distinct conformations
depending on its PBD amino acid sequence (Zhou et al., 2017).
Finally, are there other protein substrates present in Rac1 nanoclusters? I found
that Rac1 co-clusters with PLD2, likely as a result of localized PA production.
Additionally, Ras clusters are known to interact with different protein substrates that
target isoform-specific nanoclusters. For example, K-Ras clusters are regulated by
nucleolin and nucleophosmin while H-Ras clusters are dependent on caveolin and
galectin-1 (Belanis et al., 2008, Inder et al., 2009, Roy et al., 1999). An exciting avenue
of exploration will be to determine key signaling proteins in the Rac1 clusters and how
they are recruited, especially among different cell types and in Rac1-mediated diseases.
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